Case number 1:18-cv-01892
Galderma Laboratories, L.P. et al v. Medinter US LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 10, 2023 | 468 | SO ORDERED, re 465 MOTION to Seal Document: Galderma's Brief in Support of Renewed Motion for Default Judgment. Signed by Judge Joshua D. Wolson on 10/10/2023. (smg) (Entered: 10/10/2023) (1) |
| Oct 6, 2023 | 465 | MOTION to Seal Document: Galderma's Brief in Support of Renewed Motion for Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 10/06/2023) (3) |
| Oct 6, 2023 | 466 | MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 10/06/2023) (5) |
| Oct 6, 2023 | 467 | [SEALED] OPENING BRIEF in Support re 466 MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC (Renewed) - filed by Galderma Laboratories, L.P., Galderma S.A..Answering Brief/Response due date per Local Rules is 10/20/2023. (Attachments: # 1 Ex. A - Feb. 23, 2023 Hearing Tr, # 2 Ex. B - Tate Expert Report (Damages), # 3 Ex. C - Greathouse Depo. Tr, # 4 Ex. D - Email A. Barraza to K. Greathouse (DermAvance0001018), # 5 Ex. E - Letter from A. Barraza to K. Greathouse (MED00015833), # 6 Ex. F - Bowman Expert Report (Infringement), # 7 Ex. G - Barraza Depo. Tr.)(Flynn, Michael) (Entered: 10/06/2023) (0) |
| Sep 21, 2023 | 464 | SO ORDERED, re 463 Stipulation of Dismissal with Prejudice filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Joshua D. Wolson on 09/21/2023. (smg) (Entered: 09/21/2023) (2) |
| Sep 19, 2023 | 463 | STIPULATION of Dismissal with Prejudice - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/19/2023) (2) |
| Sep 1, 2023 | 460 | REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023) (0) |
| Sep 1, 2023 | 461 | REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023) (21) |
| Sep 1, 2023 | 462 | Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,,. (Schnapp, Zachary) (Entered: 09/01/2023) (1) |
| Aug 24, 2023 | 459 | ORDER, Galderma's Motion For Default Judgment (D.I. 445 ) is DENIED WITHOUT PREJUDICE pending final resolution of the claims against the Individual Defendants. The Parties' Joint Motion To Seal (D.I. 457 ) is GRANTED IN PART and DENIED IN PART as follows: The Motion is GRANTED as to Galderma's proposed redactions; the Motion is DENIED as to the Individual Defendants' proposed redactions. The Parties' Joint Motion To Seal Their Motion To Seal (D.I. 458 ) is GRANTED IN PART and DENIED IN PART to the same extent as their Motion To Seal. On or before September 1, 2023, the Individual Defendants shall file unredacted versions of any materials for which I have denied leave to file under seal. (See Order for further details). Signed by Judge Joshua D. Wolson on 8/28/2023. (twk) (Entered: 08/28/2023) (8) |
| Aug 17, 2023 | 457 | [SEALED] Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibit A - Declaration of David Banchik, # 2 Exhibit B - Declaration of Joseph Mahoney, # 3 Exhibit 1 - 7-17-23 email, # 4 Exhibit 2 - redacted version of Ex. 6, # 5 Exhibit 3 - redacted version of Ex. 7, # 6 Exhibit 4 - redacted version of Ex. 65, # 7 Exhibit 5 - 7-19-23 email, # 8 Exhibit 6 - 7-20-23 email, # 9 Exhibit 7 - 7-21-23 email, # 10 Exhibit 8 - 8-9-23 email, # 11 Appendix 1 - Plaintiffs' Position, # 12 Appendix 2, part 1 - Individual Defendants' Position, # 13 Appendix 2, part 2 - Individual Defendants' Position, # 14 Appendix 3 - proposed redactions to Reply Brief)Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 458 | Joint MOTION to Seal Document: 457 Joint MOTION to Seal Document: 446 Opening Brief in Support, 452 Reply Brief, // Joint Motion to Seal Portions of Galderma's Opening and Reply Brief in Support of Its Motion for Entry of Default Judgment - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 08/17/2023) (2) |
| Aug 14, 2023 | 456 | NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Production, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Requests for Production, (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Interrogatories, (4) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Angel Barraza y Del Toro's First Set of Interrogatories and (5) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Brenda J. Farrington's First Set of Requests for Admission - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 08/14/2023) (3) |
| Aug 10, 2023 | 455 | STIPULATION AND ORDER, The Parties will file the Joint Motion to Seal on or before August 17, 2023. (Notice of Compliance deadline set for 8/17/2023.) Signed by Judge Joshua D. Wolson on 8/10/2023. (apk) (Entered: 08/10/2023) (2) |
| Aug 9, 2023 | 454 | STIPULATION TO EXTEND TIME to file Joint Motion to Seal to August 17, 2023 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 08/09/2023) (2) |
| Aug 3, 2023 | 453 | ORDER, upon review of the docket, which shows that Plaintiff Galderma Laboratories L.P. filed its Opening Brief In Support Of Its Motion For Default Judgment (D.I. 446 ) and its Reply Brief In Support Of Its Motion For Default Judgment (D.I. 452 ) under seal, but did not file a motion to seal either brief, it is ORDERED that on or before August 10, 2023, Galderma Shall file a Motion to Seal both documents, in accordance with the governing Protective Order in this matter (D.I. 93 ). Signed by Judge Joshua D. Wolson on 8/3/2023. (mpb) (Entered: 08/03/2023) (1) |
| Aug 2, 2023 | 452 | [SEALED] REPLY BRIEF re 445 MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A)(Flynn, Michael) (Entered: 08/02/2023) (0) |
| Jul 26, 2023 | 451 | ANSWERING BRIEF in Opposition re 445 MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC filed by Angel Barraza Y Del Toro, Brenda J. Farrington.Reply Brief due date per Local Rules is 8/2/2023. (Harris, John) (Entered: 07/26/2023) (14) |
| Jul 21, 2023 | 450 | REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibits A-C, # 2 Exhibits D-G)(Flynn, Michael) (Entered: 07/21/2023) (0) |
| Jul 14, 2023 | 447 | NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Rule 26(a)(1) Initial Disclosures - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 07/14/2023) (3) |
| Jul 14, 2023 | 448 | INITIAL DISCLOSURES pursuant to Rule 26 filed by Angel Barraza Y Del Toro, Brenda J. Farrington.(Harris, John) (Entered: 07/14/2023) (3) |
| Jul 14, 2023 | 449 | NOTICE OF SERVICE of Defendant Brenda J. Farringtons First Set of Interrogatories, Requests for Production of Documents, and Requests for Admission Directed to Plaintiffs Galderma Laboratories, L.P. and Galderma S.A. and Defendant Angel Barraza y del Toros First Set of Interrogatories and Requests for Production of Documents Directed to Plaintiffs Galderma Laboratories, L.P. and Galderma S.A. filed by Angel Barraza Y Del Toro, Brenda J. Farrington.(Harris, John) (Entered: 07/14/2023) (3) |
| Jul 12, 2023 | 445 | MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 07/12/2023) (5) |
| Jul 12, 2023 | 446 | [SEALED] OPENING BRIEF in Support re 445 MOTION for Default Judgment as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC filed by Galderma Laboratories, L.P., Galderma S.A..Answering Brief/Response due date per Local Rules is 7/26/2023. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Exs. C-G)(Flynn, Michael) (Entered: 07/12/2023) (0) |
| Jun 29, 2023 | 444 | REDACTED VERSION of 430 Letter by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 06/29/2023) (30) |
| Jun 28, 2023 | 443 | ORAL ORDER: Pursuant to Section G of the Administrative Procedures Governing Filing and Service by Electronic Means, a redacted version of D.I. 430 should have been filed electronically on May 24, 2023. No such redacted version has yet been filed, even after the Court's June 21, 2023 Redaction Notice reminder. The Court hereby ORDERS that by no later than June 29, 2023, Plaintiffs shall file a redacted version of D.I. 430. If no such redacted version is filed, the Court will unseal D.I. 430. Ordered by Judge Christopher J. Burke on 6/28/2023. (mlc) (Entered: 06/28/2023) (0) |
| Jun 23, 2023 | 442 | SO ORDERED D.I. 441 Scheduling Order: Fact Discovery completed by 9/29/2023., Dispositive Motions due by 12/1/2023., Answering Brief due 1/12/2024., Reply Brief due 2/9/2024. Pretrial conference and trial dates to be determined. See Scheduling Order for further deadlines. Ordered by Judge Christopher J. Burke on 6/23/2023. (mlc) (Entered: 06/23/2023) (0) |
| Jun 22, 2023 | 439 | REDACTED VERSION of 431 Letter, from John G. Harris, Esquire to The Honorable Christopher J. Burke dated May 24, 2023 regarding the Individual Defendants' Letter Brief in Response by Angel Barraza Y Del Toro, Brenda J. Farrington. (Harris, John) (Entered: 06/22/2023) (6) |
| Jun 22, 2023 | 440 | REDACTED VERSION of 436 Letter, to The Honorable Christopher J. Burke from John G. Harris, Esquire regarding Individual Defendants' Submission in support of their Proposed Case Schedule - re 433 Oral Order by Angel Barraza Y Del Toro, Brenda J. Farrington. (Attachments: # 1 Text of Proposed Order Proposed Case Scheduling Order, # 2 Exhibit A - D)(Harris, John) (Entered: 06/22/2023) (0) |
| Jun 22, 2023 | 441 | STIPULATION and [Proposed] Case Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 06/22/2023) (2) |
| Jun 16, 2023 | 438 | ORAL ORDER: The Court, having reviewed the parties' June 7, 2023 letters regarding the proposed case schedule, (D.I. 435; D.I. 436), and having discussed the matter with the assigned District Judge, hereby ORDERS as follows: (1) The Court will enter a case schedule with dates that are not contingent on the Court's resolution of the pending motions to dismiss. The Court will not set dates for the pretrial conference and trial at this time. The District Judge does not currently intend to grant extensions to the summary judgment deadline.; and (2) The fact discovery cut off deadline shall be September 29, 2023. The deadline for opening briefs in support of case dispositive motions shall be December 1, 2023. By no later than June 23, 2023, the parties shall agree on the remaining deadlines and submit a jointly-proposed Scheduling Order. Ordered by Judge Christopher J. Burke on 6/16/2023. (mlc) (Entered: 06/16/2023) (0) |
| Jun 12, 2023 | 437 | NOTICE OF SERVICE of Defendants Brenda J. Farrington and Angel Barraza y del Toro's Supplemental Responses and Objections to Galderma Laboratories, L.P. and Galderma S.A.'s Interrogatory Nos. 1, 2, 3, 4, 6, and 7. re 434 Oral Order,,,,,,,,,,,,, Terminate Hearings,,,,,,,,,,,, filed by Angel Barraza Y Del Toro, Brenda J. Farrington.(Harris, John) (Entered: 06/12/2023) (2) |
| Jun 7, 2023 | 435 | Letter to The Honorable Christopher J. Burke from Michael Flynn regarding Proposed Schedule. (Attachments: # 1 Exs. A-D)(Flynn, Michael) (Entered: 06/07/2023) (0) |
| Jun 7, 2023 | 436 | [SEALED] Letter to The Honorable Christopher J. Burke from John G. Harris, Esquire regarding Individual Defendants' Submission in support of their Proposed Case Schedule - re 433 Oral Order,,,,,,,,, 434 Oral Order,,,,,,,,,,,,, Terminate Hearings,,,,,,,,,,,,. (Attachments: # 1 Text of Proposed Order Proposed Scheduling Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Harris, John) (Main Document 436 replaced on 6/8/2023) (dlb). (Entered: 06/07/2023) (0) |
| Jun 5, 2023 | 433 | ORAL ORDER: The Court, having reviewed Plaintiffs' discovery motion, (D.I. 429), and the briefing related thereto, (D.I. 430; D.I. 431; D.I. 432), hereby ORDERS as follows: (1) With regard to the portion of Section I of Plaintiffs' opening letter brief in which Plaintiffs generally complain that Individual Defendants' discovery responses are not "compliant" or are "inadequate and incomplete[,]" (D.I. 430 at 1-2), it is DENIED without prejudice to renew. The letter brief does not actually explain, in the text of Section I, what these deficiencies are. To the extent that certain deficiencies are being pressed here beyond what is described in the remainder of the letter, insufficient information has been provided in order for the Court to make a ruling on them.; (2) With regard to the portion of Section I that asks that a case schedule be entered, and to Section III (which asks for the same thing), (id. at 2, 4), that request is GRANTED. The Court already advised the parties that a case schedule should be entered at this stage, and regrettably, Individual Defendants have effectively stymied that process so far by not meaningfully putting forward a view of what such a schedule should look like. (Id., ex. M at 76) By no later than June 7, 2023, the parties shall submit a jointly-proposed Scheduling Order for the remainder of this case. If they have disputes about the dates by which certain case events should occur, they may include a cover letter of no more than two single-spaced pages that sets out the nature of their disagreement in that regard and the reasons why each side thinks its proposed dates are more equitable.; (3) With regard to Section IV, (id. at 4), Plaintiffs may file their anticipated motion for default judgment whenever they are ready to do so. They should support any request for damages with whatever appropriate argument, affidavits, declarations, itemized statements and the like they believe are necessary to meet their burden, in order to obtain the type of damages award they seek. See Sisvel Int'l S.A. v. AnyData Corp., C.A. No. 19-1140-MN, 2021 WL 5168895, at *2-3 (D. Del. Oct. 27, 2021); Tristrata Tech., Inc. v. Med. Skin Therapy Research, Inc., 270 F.R.D. 161, 164-65 (D. Del. 2010). Beyond this, the Court has no particular preference for how Plaintiffs may try to meet their burden to show entitlement to relief.Ordered by Judge Christopher J. Burke on 6/5/2023. (mlc) (Entered: 06/05/2023) (0) |
| Jun 5, 2023 | 434 | ORAL ORDER: The Court, having reviewed Plaintiffs' discovery motion, (D.I. 429 ), and the briefing related thereto, (D.I. 430; D.I. 431; D.I. 432), hereby ORDERS as follows with regard to the portion of Section II of Plaintiffs' opening letter: (1) With regard to the request for supplementation of ROGs 1-3, it is DENIED. ROGs 1 and 3 are incredibly overbroad and are facially unduly burdensome to respond to, as they essentially ask the Individual Defendants ("IDs") to explain every fact relating to every financial transaction involving the Corporate Defendants ("CDs") over a decade-plus period. ROG 2 is more narrowly drawn (to payments the IDs received from the CDs), but the answers provided appear responsive and sufficiently detailed. (D.I. 430, ex. D at 6; id., ex. F at 5); (2) With regard to the request for supplementation of ROG 4, it is DENIED. That ROG is also extremely overbroad in a similar way as ROGs 1 and 3, with the exception of its request for information about the "two-factor authentication" issue (which the IDs addressed in detail in their responses). (Id., ex. D at 7-9; id., ex. F at 7); (3) With regard to the request for supplementation of ROG 5, it is DENIED. The ROG suffers from the same overbreadth deficiencies as ROGs 1 and 3, and to the extent it asks for information about efforts to sell the CDs, the IDs both responded by saying that there were no such efforts. (Id., ex. D at 9; id., ex. F at 7); (4) With regard to the request for supplementation of ROGs 6 and 7, it is GRANTED. Plaintiffs explained the relevance of the requests, (D.I. 430 at 3), and the IDs agreed to supplement, (D.I. 431 at 3).; (5) With regard to the request for supplementation of ROG 8, it is DENIED. The ROG suffers from similar overbreadth deficiencies as with ROGs 1 and 3, in that it asks for a response regarding any document or communication relating to 21 different types of acts relating to the Accused Products.; (6) With regard to the ROGs, although the Court has denied many of the requests above, if the IDs had previously agreed to supplement their answers to the ROGs in a certain way (as is described in the IDs' letter brief), (Id. at 2-3), then the IDs must do so; the Court's denials here simply mean that no further supplementation is required at this time. To the extent supplemental responses to the ROGs were ordered herein or to the extent IDs have otherwise agreed to provide them, they must be provided by no later than June 11, 2023.; (7) With regard to Plaintiffs' request that the Court compel responsive document productions regarding Plaintiffs' RFPs, the request is GRANTED in that the IDs must continue their rolling production of documents, and such production should be substantially complete by no later than 30 days from today's date (absent further Court order indicating otherwise).; and (8) Today's videoconference is hereby CANCELED. Ordered by Judge Christopher J. Burke on 6/5/2023. (mlc) (Entered: 06/05/2023) (0) |
| May 30, 2023 | 432 | Letter to The Honorable Christopher J. Burke from Michael J. Flynn regarding Plaintiffs' Reply Letter Brief - re 431 Letter,. (Flynn, Michael) (Entered: 05/30/2023) (3) |
| May 24, 2023 | 431 | [SEALED] Letter to The Honorable Christopher J. Burke from John G. Harris, Esq. regarding Individual Defendants' Letter Brief in Response - re 428 Order Setting Videoconference,,,,,,,, 430 Letter, 429 Joint MOTION for Hearing / Videoconference to Resolve Discovery Disputes and Scheduling, 427 Letter. (Harris, John) (Entered: 05/24/2023) (0) |
| May 17, 2023 | 430 | [SEALED] Letter to The Honorable Christopher J. Burke from Michael Flynn regarding the Court's Oral Order (D.I. 428; see also D.I. 427). (Attachments: # 1 Exs. A-M)(Flynn, Michael) (Entered: 05/17/2023) (0) |
| May 11, 2023 | 429 | Joint MOTION for Hearing / Videoconference to Resolve Discovery Disputes and Scheduling - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 05/11/2023) (2) |
| May 10, 2023 | 428 | ORAL ORDER Setting Videoconference: The Court has reviewed Plaintiffs' May 9, 2023 letter requesting a discovery dispute and status teleconference regarding three discovery disputes and guidance regarding a motion for default judgment. (D.I. 427) It hereby ORDERS as follows with regard to these issues: (1) A discovery dispute and status videoconference using the Microsoft Teams platform is set for June 5, 2023 at 1:00 PM before Judge Christopher J. Burke.; (2) By May 17, 2023, Plaintiffs shall file with the Court a letter, not to exceed four (4) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues, including a summary of the guidance it seeks regarding a motion for default judgment against the Corporate Defendants.; (3) By May 24, 2023, the Individual Defendants may file a letter, not to exceed four (4) single-spaced pages, in no less than 12-point font, outlining that party's reasons for its opposition.; (4) By May 30, 2023, Plaintiffs shall file with the Court a reply letter brief, not to exceed one (1) single-spaced page, in no less than 12-point font.; (5) The parties shall jointly file a Motion For Videoconference To Resolve Discovery Dispute.; (6) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (7) By no later than May 24, 2023, the parties shall send an e-mail to the Court's Courtroom Deputy, Ms. Benyo, indicating the names and e-mail addresses of all individuals who will participate in the videoconference.; and (8) The Court may choose to resolve the disputes prior to the videoconference and will, in that event, cancel the videoconference (however, if any party advises the Court in advance that a newer attorney will argue the disputes, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference). Ordered by Judge Christopher J. Burke on 5/10/2023. (dlb) (Entered: 05/10/2023) (0) |
| May 9, 2023 | 427 | Letter to The Honorable Christopher J. Burke from Michael J. Flynn regarding Plaintiffs' request the scheduling of a discovery and status teleconference. (Flynn, Michael) (Entered: 05/09/2023) (2) |
| May 4, 2023 | 425 | ORDER granting 422 REQUEST for Default as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC filed by Galderma S.A., Galderma Laboratories, L.P.. Signed by Judge Christopher J. Burke on 5/4/2023. (dlb) (Entered: 05/04/2023) (1) |
| May 4, 2023 | 426 | Clerk's ENTRY OF DEFAULT as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC (dlb) (dlb). (Entered: 05/04/2023) (1) |
| Apr 28, 2023 | 423 | ORAL ORDER: The Court, having reviewed Plaintiffs' Motion for Entry of Default, (D.I. 422), and in light of the circumstances described therein, hereby ORDERS that the Court intends to enter default pursuant to Federal Rule of Civil Procedure 55(a) on May 4, 2023, unless new counsel for the Corporate Defendants enters an appearance prior to that date. See, e.g., Genedics, LLC v. Meta Co., Civil Action No. 17-1062-CJB, 2019 WL 3802650, at *2 (D. Del. Aug. 13, 2019). Counsel for the Individual Defendants shall advise the Individual Defendants (who are principals of the Corporate Defendants) of the content of this Oral Order. Ordered by Judge Christopher J. Burke on 4/28/23. (mlc) (Entered: 04/28/2023) (0) |
| Apr 28, 2023 | 424 | STIPULATION to Amend Protective Order - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 04/28/2023) (2) |
| Apr 27, 2023 | 420 | REDACTED VERSION of 417 Reply Brief in Further Support of Defendant Angel Barraza y del Toro's Motion to Dismiss by Angel Barraza Y Del Toro. (Schnapp, Zachary) (Entered: 04/27/2023) (15) |
| Apr 27, 2023 | 421 | REDACTED VERSION of 416 Reply Brief in Further Support of Defendant Brenda J. Farrington's Motion to Dismiss by Brenda J. Farrington. (Schnapp, Zachary) (Entered: 04/27/2023) (15) |
| Apr 27, 2023 | 422 | REQUEST for Default as to Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 04/27/2023) (6) |
| Apr 19, 2023 | 416 | [SEALED] REPLY BRIEF re 398 MOTION to Dismiss for Failure to State a Claim Defendant Brenda J. Farrington's Motion to Dismiss filed by Brenda J. Farrington. (Schnapp, Zachary) (Entered: 04/19/2023) (0) |
| Apr 19, 2023 | 417 | [SEALED] REPLY BRIEF re 402 MOTION to Dismiss for Failure to State a Claim [Defendant Angel Barraza Y Del Toro's Motion to Dismiss] filed by Angel Barraza Y Del Toro. (Schnapp, Zachary) (Entered: 04/19/2023) (0) |
| Apr 19, 2023 | 418 | CERTIFICATE OF SERVICE of Reply Brief in Further Support of Defendant Brenda J. Farrington's Motion to Dismiss by Brenda J. Farrington re 416 Reply Brief (Schnapp, Zachary) (Entered: 04/19/2023) (1) |
| Apr 19, 2023 | 419 | CERTIFICATE OF SERVICE of Reply Brief in Further Support of Defendant Angel Barraza y del Toro's Motion to Dismiss by Angel Barraza Y Del Toro re 417 Reply Brief (Schnapp, Zachary) (Entered: 04/19/2023) (1) |
| Apr 12, 2023 | 414 | REDACTED VERSION of 411 Answering Brief in Opposition, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 04/12/2023) (27) |
| Apr 12, 2023 | 415 | REDACTED VERSION of 412 Answering Brief in Opposition, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 04/12/2023) (27) |
| Apr 10, 2023 | 413 | Joint MOTION for Extension of Time to File Response/Reply as to 411 Answering Brief in Opposition, 402 MOTION to Dismiss for Failure to State a Claim [Defendant Angel Barraza Y Del Toro's Motion to Dismiss], 398 MOTION to Dismiss for Failure to State a Claim Defendant Brenda J. Farrington's Motion to Dismiss, 412 Answering Brief in Opposition, 403 Opening Brief in Support, 399 Opening Brief in Support, extended through Wednesday, April 19, 2023 - filed by Angel Barraza Y Del Toro, Brenda J. Farrington. Motions referred to Christopher J. Burke.(Harris, John) (Entered: 04/10/2023) (2) |
| Apr 5, 2023 | 411 | [SEALED] ANSWERING BRIEF in Opposition re 402 MOTION to Dismiss for Failure to State a Claim [Defendant Angel Barraza Y Del Toro's Motion to Dismiss] - filed by Galderma Laboratories, L.P., Galderma S.A..Reply Brief due date per Local Rules is 4/12/2023. (Flynn, Michael) (Entered: 04/05/2023) (0) |
| Apr 5, 2023 | 412 | [SEALED] ANSWERING BRIEF in Opposition re 398 MOTION to Dismiss for Failure to State a Claim Defendant Brenda J. Farrington's Motion to Dismiss - filed by Galderma Laboratories, L.P., Galderma S.A..Reply Brief due date per Local Rules is 4/12/2023. (Flynn, Michael) (Entered: 04/05/2023) (0) |
| Mar 30, 2023 | 410 | NOTICE OF SERVICE of (1) Defendant Brenda J. Farringtons Responses and Objections to Galderma Laboratories, L.P. and Galderma S.A.s Interrogatories; (2) Defendant Angel Barraza y del Toros Responses and Objections to Galderma Laboratories, L.P. and Galderma S.A.s Interrogatories; (3) Defendant Brenda J. Farringtons Responses and Objections to Galderma Laboratories, L.P. and Galderma S.A.s Requests for Production of Documents and Things; and (4) Defendant Angel Barraza y del Toros Responses and Objections to Galderma Laboratories, L.P. and Galderma S.A.s Requests for Production of Documents and Things. re 397 Notice of Service, filed by Angel Barraza Y Del Toro, Brenda J. Farrington.(Harris, John) (Entered: 03/30/2023) (3) |
| Mar 27, 2023 | 409 | ORAL ORDER: The Court, having reviewed the March 24, 2023 letter from the principal of the Corporate Defendants requesting a 30-day extension of the current stay, (D.I. 408), hereby ORDERS that the request is GRANTED. The Corporate Defendants are granted an additional 30 days (until April 26, 2023) to obtain substitute counsel. Ordered by Judge Christopher J. Burke on 3/27/2023. (dlb) (Entered: 03/27/2023) (0) |
| Mar 24, 2023 | 408 | Letter to Judge Burke from Dr. Brenda J. Farrington, Principle of Medinter regarding Request for 30-day extension of stay. (dlb) (Entered: 03/24/2023) (1) |
| Mar 14, 2023 | 405 | REDACTED VERSION of 399 Opening Brief in Support, [Memorandum of Points and Authorities in Support of Defendant Brenda J. Farrington's Motion to Dismiss] by Brenda J. Farrington. (Schnapp, Zachary) (Entered: 03/14/2023) (27) |
| Mar 14, 2023 | 406 | REDACTED VERSION of 400 Exhibit to a Document, [Exhibits A and B to Memorandum of Points and Authorities in Support of Defendant Brenda J. Farrington's Motion to Dismiss] by Brenda J. Farrington. (Attachments: # 1 Exhibit B)(Schnapp, Zachary) (Entered: 03/14/2023) (0) |
| Mar 14, 2023 | 407 | REDACTED VERSION of 403 Opening Brief in Support, [Memorandum of Points and Authorities in Support of Defendant Angel Barraza Y Del Toro's Motion to Dismiss with Exhibits A and B] by Angel Barraza Y Del Toro. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Schnapp, Zachary) (Entered: 03/14/2023) (0) |
| Mar 8, 2023 | 398 | MOTION to Dismiss for Failure to State a Claim Defendant Brenda J. Farrington's Motion to Dismiss - filed by Brenda J. Farrington. (Schnapp, Zachary) (Entered: 03/08/2023) (1) |
| Mar 8, 2023 | 399 | [SEALED] OPENING BRIEF in Support re 398 MOTION to Dismiss for Failure to State a Claim Defendant Brenda J. Farrington's Motion to Dismiss [Memorandum of Points and Authorities in Support of Defendant Brenda J. Farrington's Motion to Dismiss] filed by Brenda J. Farrington.Answering Brief/Response due date per Local Rules is 3/22/2023. (Schnapp, Zachary) (Entered: 03/08/2023) (0) |
| Mar 8, 2023 | 400 | [SEALED] EXHIBIT re 399 Opening Brief in Support, Exhibits A and B to Memorandum of Points and Authorities in Support of Defendant Brenda J. Farrington's Motion to Dismiss by Brenda J. Farrington. (Attachments: # 1 Certificate of Compliance Exhibit B)(Schnapp, Zachary) (Entered: 03/08/2023) (0) |
| Mar 8, 2023 | 401 | CERTIFICATE OF SERVICE of Certificate of Service to Memorandam of Points and Authorities in Support of Defendant Brenda J. Farrington's Motion to Dismiss with Exhibits A and B by Brenda J. Farrington re 400 Exhibit to a Document, 399 Opening Brief in Support, (Schnapp, Zachary) (Entered: 03/08/2023) (1) |
| Mar 8, 2023 | 402 | MOTION to Dismiss for Failure to State a Claim [Defendant Angel Barraza Y Del Toro's Motion to Dismiss] - filed by Angel Barraza Y Del Toro. (Schnapp, Zachary) (Entered: 03/08/2023) (1) |
| Mar 8, 2023 | 403 | [SEALED] OPENING BRIEF in Support re 402 MOTION to Dismiss for Failure to State a Claim [Defendant Angel Barraza Y Del Toro's Motion to Dismiss] [Memorandum of Points and Authorities in Support of Defendant Angel Barraza Y Del Toro's Motion to Dismiss] filed by Angel Barraza Y Del Toro.Answering Brief/Response due date per Local Rules is 3/22/2023. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B)(Schnapp, Zachary) (Entered: 03/08/2023) (0) |
| Mar 8, 2023 | 404 | CERTIFICATE OF SERVICE of Memorandum of Points and Authorities in Support of Defendant Angel Barraza Y Del Toro's Motion to Dismiss by Angel Barraza Y Del Toro re 403 Opening Brief in Support, (Schnapp, Zachary) (Entered: 03/08/2023) (1) |
| Feb 28, 2023 | 397 | NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Interrogatories to Angel Barraza y del Toro and Brenda J. Farrington and (2) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things Propounded Upon Angel Barraza y del Toro and Brenda J. Farrington - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 02/28/2023) (3) |
| Feb 27, 2023 | 395 | STIPULATION TO EXTEND TIME for (1) the Individual Defendants to respond to the Fourth Amended Complaint and (2) Plaintiffs to respond to any motion to March 8, 2023 and a two-week extension, respectively - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 02/27/2023) (2) |
| Feb 27, 2023 | 396 | SO ORDERED D.I. 395 STIPULATION TO EXTEND TIME for (1) the Individual Defendants to respond to the Fourth Amended Complaint and (2) Plaintiffs to respond to any motion to March 8, 2023 and a two-week extension, respectively filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 2/27/2023. (dlb) (Entered: 02/27/2023) (0) |
| Feb 23, 2023 | 394 | ORAL ORDER: The Court, having reviewed the Corporate Defendants' (i.e., Defendants Medinter US LLC, Medinter Ltd. (UK), Medinter Ltd. (BVI) and Medgraft Microtech, Inc.) Counsels' Motion for Leave to Withdraw as Counsel for the Corporate Defendants and for a Stay of the Case Schedule (the "Motion"), (D.I. 382), and the submissions related thereto, (see D.I. 383; D.I. 385; D.I. 388), and having heard argument on February 23, 2023, hereby ORDERS as follows: (1) During today's hearing, Plaintiffs withdrew their objection to Corporate Defendants' counsel's request for leave to withdraw from the case. In light of the fact that this aspect of the Motion is now uncontested by all parties, and after considering relevant factors applicable to such motions set out in cases like Sharp v. Verizon Del. Inc., Civil Action No. 11-1209-RGA-CJB, 2012 WL 6212615, at *2 (D. Del. Dec. 12, 2012), the Court hereby GRANTS the Motion for the reasons set out during today's hearing. The appearances of Wilson Sonsini Goodrich & Rosati, P.C. and its attorneys and their representation of the Corporate Defendants are hereby withdrawn in all aspects and for all purposes of this case. The Corporate Defendants are granted an additional 30 days to obtain substitute counsel.; (2) For the reasons discussed during the hearing, the stay of the case is LIFTED. Plaintiffs may propound written discovery requests on the Individual Defendants.; and (3) Plaintiffs and the Individual Defendants shall meet and confer and advise the Court by stipulation by no later than February 27, 2023 as to the date by which the Individual Defendants shall respond to Plaintiffs' Fourth Amended Complaint. Ordered by Judge Christopher J. Burke on 2/23/2023. (dlb) (Entered: 02/23/2023) (0) |
| Feb 22, 2023 | 393 | NOTICE of Appearance by Zachary Justin Schnapp on behalf of Angel Barraza Y Del Toro, Brenda J. Farrington (Schnapp, Zachary) (Entered: 02/22/2023) (1) |
| Feb 15, 2023 | 391 | STIPULATION TO EXTEND TIME to respond to Plaintiffs' Fourth Amended Complaint to March 1, 2023 - filed by Angel Barraza Y Del Toro, Brenda J. Farrington. (Harris, John) (Entered: 02/15/2023) (2) |
| Feb 15, 2023 | 392 | SO ORDERED D.I. 391 STIPULATION TO EXTEND TIME to respond to Plaintiffs' Fourth Amended Complaint to March 1, 2023 filed by Brenda J. Farrington, Angel Barraza Y Del Toro. Ordered by Judge Christopher J. Burke on 2/15/2023. (dlb) (Entered: 02/15/2023) (0) |
| Feb 13, 2023 | 390 | REDACTED VERSION of 385 Answering Brief in Opposition, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exs. A-E)(Flynn, Michael) (Entered: 02/13/2023) (0) |
| Feb 1, 2023 | 389 | NOTICE of Appearance by John G. Harris on behalf of Angel Barraza Y Del Toro, Brenda J. Farrington (Harris, John) (Entered: 02/01/2023) (1) |
| Jan 30, 2023 | 387 | REDACTED VERSION of 386 Declaration by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exs. A-F)(Flynn, Michael) (Entered: 01/30/2023) (0) |
| Jan 30, 2023 | 388 | REPLY to Response to Motion re 382 MOTION to Withdraw for Leave to Withdrawal as Counsel to Corporate Defendants and Stay of the Case Schedule filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # 1 Certificate of Service)(Liston, Ian) (Entered: 01/30/2023) (0) |
| Jan 27, 2023 | 386 | [SEALED] DECLARATION of Service by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C, # 4 Ex. D, # 5 Ex. E, # 6 Ex. F)(Flynn, Michael) (Entered: 01/27/2023) (0) |
| Jan 25, 2023 | 385 | [SEALED] ANSWERING BRIEF in Opposition re 382 MOTION to Withdraw for Leave to Withdrawal as Counsel to Corporate Defendants and Stay of the Case Schedule - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exhibits A to E)(Flynn, Michael) Modified on 1/26/2023 (dlb). (Entered: 01/25/2023) (0) |
| Jan 24, 2023 | 384 | ORAL ORDER: The Court, having reviewed Plaintiffs' Motion for Alternate Service ("Motion") (D.I. 361), Plaintiffs' brief, (D.I. 362), and Plaintiffs' and the Corporate Defendants' supplemental letters related thereto, (D.I. 370; D.I. 372; D.I. 379), hereby ORDERS that Plaintiffs Motion is GRANTED as follows: (1) With the Motion, Plaintiffs seek to serve the summons and Fourth Amended Complaint ("4AC") on the Individual Defendants (Brenda J. Farrington and Angel Barraza y Del Toro) by sending them via e-mail to the Individual Defendants' respective e-mail addresses and via postal mail to the Individual Defendants' home address in Spain. (D.I. 370 at 2; D.I. 379) The Individual Defendants appear to be aware of the 4AC. (D.I. 356 at 3; D.I. 359); (2) Plaintiffs seek the Courts approval for the form of alternative service described above pursuant to Federal Rule of Civil Procedure 4(f)(3), because Plaintiffs believes that service via the Hague Convention would add further delay to a case that has already been pending for years. (D.I. 362 at 3; D.I. 370 at 1); (3) A party is not required to complete efforts to try to serve a defendant through the Hague Convention before service under Rule 4(f)(3) may be permitted. See, e.g., In re TK Holdings, Bankr. Case No. 17-11375-BLS, 2021 WL 3796878, at *4 (D. Del. Aug. 26, 2021); Crockett v. Luitpold Pharms., Inc., CIVIL ACTION NO. 19-276, 2020 WL 4039046, at *1-3 (E.D. Pa. July 17, 2020). Rule 4(f)(3) permits Plaintiffs to serve a foreign defendant by any means that is "not prohibited by international agreement, as the court orders." Fed. R. Civ. P. 4(f)(3). The Court is not aware of any international agreements to which Spain is a signatory that prohibit service via e-mail and postal mail. See, e.g., Aircraft Engine Lease Fin., Inc. v. Plus Ultra Lineas Aereas, S.A., 21 Civ. 1758, 2021 WL 6621578, at *2-3 (S.D.N.Y. Apr. 23, 2021).; (4) The Corporate Defendants have not taken a formal position on the Motion. (D.I. 372) The Individual Defendants are the sole principals of the Corporate Defendants, and there are no other employees. (D.I. 362, ex. A at 106, 127-28, 133, 144-45); (5) Even if otherwise permissible under Rule 4(f)(3), the court-ordered method of service must also be reasonable and comport with constitutional notions of due process, in that it must be "reasonably calculated, under all the circumstances, to apprise [defendants] of the pendency of the action and afford [them] an opportunity to present [their] objections." Aircraft Engine Lease Fin., Inc., 2021 WL 6621578, at *2. With respect to the service by e-mail, the Individual Defendants testified under oath in March and August 2022 that the e-mail addresses that Plaintiffs intend to use were their e-mail addresses. (D.I. 379, ex. B at 364; id., ex. C at 20) Moreover, the Individual Defendants have used these e-mail addresses to correspond with one another and an attorney for the Corporate Defendants as recently as May 2022. (Id., ex. D) With respect to service by postal mail, Mrs. Farrington testified under oath in March 2022 that the address that Plaintiffs intend to use is her residential address, and that she is married to and cohabitates with Mr. Barraza. (Id., ex. A at 5, 12; id., ex. B at 502-03) On the basis of these representations, it is reasonable to believe that e-mail and postal mail service on the Individual Defendants will apprise them of the pendency of this case and of the fact that they have been served.; (6) Under these circumstances, the Court will exercise its discretion and grant the Motion, such that Plaintiffs' 4AC and summons shall be served via e-mail to the Individual Defendants' e-mail addresses and via postal mail to both Individual Defendants. Service shall be considered effective as of the date the summons and Fourth Amended Complaint are e-mailed to the Individual Defendants. Ordered by Judge Christopher J. Burke on 1/24/2023. (dlb) (Entered: 01/24/2023) (0) |
| Jan 20, 2023 | 380 | MOTION for Pro Hac Vice Appearance of Attorney Jordan R. Jaffe - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # 1 Certification of Jordan R. Jaffe)Motions referred to Christopher J. Burke.(Liston, Ian) (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 381 | REDACTED VERSION of 379 Letter - by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 A-E, # 2 Proposed Order)(Flynn, Michael) (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 382 | MOTION to Withdraw for Leave to Withdrawal as Counsel to Corporate Defendants and Stay of the Case Schedule - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # 1 Statement of Rule 7.1.1 Compliance, # 2 Proposed Order, # 3 Certificate of Service)Motions referred to Christopher J. Burke.(Liston, Ian) (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 383 | NOTICE of Filing in Camera Document by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC (Liston, Ian) (Entered: 01/20/2023) (3) |
| Jan 17, 2023 | 376 | STIPULATION and [Proposed] Order Regarding Briefing Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 01/17/2023) (2) |
| Jan 17, 2023 | 377 | SO ORDERED D.I. 376 Stipulation regarding briefing scheduled filed by Galderma S.A., Galderma Laboratories, L.P.. Ordered by Judge Christopher J. Burke on 1/17/2023. (dlb) (Entered: 01/17/2023) (0) |
| Jan 17, 2023 | 378 | ORAL ORDER: The Court hereby ORDERS that a hearing on the Corporate Defendants' forthcoming Motion to Withdraw is set for February 23, 2023 at 11:00 am in Courtroom 2A. Ordered by Judge Christopher J. Burke on 1/17/2023. (dlb) (Entered: 01/17/2023) (0) |
| Jan 17, 2023 | 379 | [SEALED] Letter to The Honorable Christopher J. Burke from Michael Flynn regarding supplemental letter brief pursuant to the Court's oral order (D.I. 375). (Attachments: # 1 Exs. A-E, # 2 Proposed Order)(Flynn, Michael) (Entered: 01/17/2023) (0) |
| Jan 12, 2023 | 375 | ORAL ORDER: The Court, having reviewed Plaintiffs' Motion for Alternate Service ("Motion") (D.I. 361), as well as Plaintiffs' and the Corporate Defendants' supplemental letters related thereto, (D.I. 370; D.I. 372), including Plaintiffs' alternative request for permission to effect service on the Individual Defendants via electronic mail and via certified mail to the Individual Defendants' home address, (D.I. 370 at 2), hereby ORDERS that by no later than January 17, 2023, Plaintiffs shall submit a supplemental letter of no longer than two single-spaced pages that provides additional details that would help assure the Court that that the e-mail addresses and home address that Plaintiffs intend to utilize appear to be accurate addresses that would be reasonably calculated to apprise the Individual Defendants of the pendency of the action. See Aircraft Engine Lease Fin., Inc. v. Plus Ultra Lineas Aereas, S.A., 21 Civ. 1758, 2021 WL 6621578, at *2-3 (S.D.N.Y. Apr. 23, 2021). Ordered by Judge Christopher J. Burke on 1/12/2023. (mlc) (Entered: 01/12/2023) (0) |
| Jan 11, 2023 | 374 | ORAL ORDER: The Court, having reviewed Corporate Defendants' Emergency Motion for a Stay ("Motion for a Stay"), (D.I. 368), and Plaintiffs' opposition thereto, (D.I. 373), and having considered the three stay-related factors, hereby ORDERS that the Motion for a Stay is GRANTED for the reasons that follow: (1) First, all that the Court is deciding now is whether to stay the case for a relatively short time period pending resolution of the forthcoming Motion to Withdraw as Counsel ("Motion to Withdraw"). The requested stay is not an indefinite one, and the Court will endeavor to resolve the Motion to Withdraw as quickly as it can.; (2) Counsel for the Corporate Defendants ("Wilson Sonsini") has asserted that it will be seeking leave to withdraw not only because of unpaid legal fees, but also for privileged reasons, which suggests that there could be serious ethical issues implicated by the Motion to Withdraw. (D.I. 368 at 4; D.I. 372 at 2) The Motion to Withdraw may present difficult issues on both sides and will likely deserve a hearing. If the Court were to deny the Motion for a Stay, that would seem tantamount to essentially denying (at least in part) the Motion to Withdraw before the Motion to Withdraw had even been filed and briefed (in the sense that, in the interval between now and when the Motion to Withdraw would be resolved, Wilson Sonsini would be required to continue representing the Corporate Defendants in a number of key pre-trial depositions -- i.e., it would be denied the very relief it seeks).; (3) Many of Plaintiffs' arguments in opposition to the Motion for a Stay are really arguments as to why Wilson Sonsini should not be permitted to withdraw in the case, as opposed to arguments about why the Court should not grant a brief stay pending resolution of the Motion to Withdraw. (D.I. 373 at 6-8) Plaintiffs may make these arguments in any opposition to the Motion to Withdraw.; (4) The case was likely to run into some delay even were the Court to not grant the Motion for a Stay, due to the fact that Plaintiffs chose to add the Individual Defendants to the case close to the summary judgment deadline.; (5) For these reasons, the case is hereby STAYED pending resolution of the Motion to Withdraw.; and (6) Wilson Sonsini intends to file the Motion to Withdraw on January 20, 2023. (D.I. 368 at 1) By no later than January 17, 2023, the parties shall meet and confer and submit a stipulation setting out a truncated briefing schedule for the Motion to Withdraw, including a date by which Wilson Sonsini shall submit an in-camera letter to the Court providing further details regarding the privileged reasons driving the Motion to Withdraw. The Court will thereafter set a hearing on the Motion to Withdraw. Ordered by Judge Christopher J. Burke on 1/11/2023. (mlc) (Entered: 01/11/2023) (0) |
| Jan 10, 2023 | 371 | Joint STIPULATION extend time for Plaintiffs to file opposition to Motion to Stay by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) (Entered: 01/10/2023) (2) |
| Jan 10, 2023 | 372 | Letter to the Hon. Christopher J. Burke from Ian R. Liston regarding Plaintiffs' Supplemental Letter Brief Regarding Motion for Alternative Service - re 370 Letter. (Liston, Ian) (Entered: 01/10/2023) (2) |
| Jan 10, 2023 | 373 | RESPONSE to Motion re 368 Emergency MOTION to Stay Pending Resolution of Forthcoming Motion to Withdraw (Plaintiffs' Opposition to Defendants' Emergency Motion for a Stay) - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exs. A-C)(Flynn, Michael) (Entered: 01/10/2023) (0) |
| Jan 9, 2023 | 370 | Letter to The Honorable Christopher J. Burke from Michael Flynn - re 361 MOTION for Alternate Service . (Flynn, Michael) (Entered: 01/09/2023) (2) |
| Jan 7, 2023 | 369 | STATEMENT re 368 Emergency MOTION to Stay Pending Resolution of Forthcoming Motion to Withdraw re Rule 7.1.1 Compliance by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) (Entered: 01/07/2023) (3) |
| Jan 6, 2023 | 368 | Emergency MOTION to Stay Pending Resolution of Forthcoming Motion to Withdraw - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Text of Proposed Order, # 6 Certificate of Service)Motions referred to Christopher J. Burke.(Liston, Ian) (Attachment 6 replaced on 1/9/2023) (mpb). (Entered: 01/06/2023) (0) |
| Jan 5, 2023 | 367 | NOTICE requesting Clerk to remove G. Edward Powell III as co-counsel. Reason for request: No longer associated with Wilson Sonsini Goodrich & Rosati, P.C.. (Liston, Ian) (Entered: 01/05/2023) (2) |
| Dec 30, 2022 | 365 | REDACTED VERSION of 361 MOTION for Alternate Service by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 12/30/2022) (5) |
| Dec 30, 2022 | 366 | REDACTED VERSION of 362 Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exs. A-C)(Flynn, Michael) (Entered: 12/30/2022) (0) |
| Dec 28, 2022 | 363 | REDACTED VERSION of 358 Answer to Amended Complaint by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) (Entered: 12/28/2022) (30) |
| Dec 28, 2022 | 364 | NOTICE OF SERVICE of Reply Report of Dr. Sarah Heilshort, Ph.D filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) (Entered: 12/28/2022) (3) |
| Dec 22, 2022 | 360 | NOTICE OF SERVICE of (1) Rebuttal Expert Report of Michael E. Tate, (2) Expert Reply Report of Prof. Christopher Bowman, Ph.D. Regarding Infringement, (3) Expert Report of Dr. Ulrich Worm and (4) Expert Rebuttal Report of Dr. John H. Joseph, M.D. - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 12/22/2022) (3) |
| Dec 22, 2022 | 361 | [SEALED] MOTION for Alternate Service - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) (Entered: 12/22/2022) (0) |
| Dec 22, 2022 | 362 | [SEALED] Letter to The Honorable Christopher J. Burke from Michael Flynn - re 361 MOTION for Alternate Service . (Attachments: # 1 A-C)(Flynn, Michael) (Entered: 12/22/2022) (0) |
| Dec 21, 2022 | 359 | Letter to The Honorable Christopher J. Burke from Ian R. Liston regarding Representation of Defendants Dr. Brenda Farrington and Angel Barraza - re 357 Oral Order,,,. (Liston, Ian) (Entered: 12/21/2022) (1) |
| Dec 20, 2022 | 358 | [SEALED] ANSWER to Amended Complaint, re: 353 Amended Complaint, with JURY DEMAND by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # 1 Certificate of Service)(Liston, Ian) (Entered: 12/20/2022) (0) |
| Dec 15, 2022 | 357 | ORAL ORDER: The Court, having reviewed the parties' December 15, 2022 letter, (D.I. 356), hereby ORDERS that by no later than December 21, 2022, counsel for the Corporate Defendants shall submit a status report of no longer than two single-spaced pages that updates the Court as to whether they will be representing the Individual Defendants (and if so, whether the Individual Defendants are in agreement with the schedule to which Plaintiffs and the Corporate Defendants have agreed, and the scope of discovery to be served on the Individual Defendants). To the extent that Plaintiffs and the Corporate Defendants wish the Court to enter the proposed schedule as to solely as to them in the interval, they shall submit a stipulation and proposed amended scheduling order that the Court may then enter. Ordered by Judge Christopher J. Burke on 12/15/2022. (dlb) (Entered: 12/15/2022) (0) |
| Dec 14, 2022 | 356 | [SEALED] Letter to The Honorable Christopher J. Burke from Michael Flynn regarding Joint Status Report - re Motion Hearing,,. (Attachments: # 1 Exhibits A to E)(Flynn, Michael) (Entered: 12/14/2022) (0) |
| Dec 13, 2022 | 355 | Amended Complaint* (1) |
| Dec 12, 2022 | 354 | Joint STIPULATION Extension of Time to Submit Joint Status Report by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) (Entered: 12/12/2022) (2) |
| Dec 6, 2022 | 353 | [SEALED] Fourth AMENDED COMPLAINT against Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC, Angel Barraza Y Del Toro, Brenda J. Farrington- filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Exs. A-Z, # 2 Exs. AA-WW)(Flynn, Michael) (Entered: 12/06/2022) (0) |
| Nov 23, 2022 | 352 | NOTICE OF SERVICE of Rebuttal Expert Report of Stephen Spiegelberg, Ph.D., the Rebuttal Report of Dr. Sarah Heilshorn, Ph.D. and the Rebuttal Expert Report of Meghan Muscato filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) (Entered: 11/23/2022) (3) |
| Nov 22, 2022 | 351 | NOTICE OF SERVICE of (1) Expert Report of Michael E. Tate Regarding the Commercial Success of U.S. Patent Nos. 6,716,251 and 7,731,758; (2) Expert Rebuttal Report of Prof. Christopher Bowman, Ph.D. Regarding Validity; and (3) Expert Rebuttal Report of Dr. John H. Joseph, M.D. Regarding Validity filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) (Entered: 11/22/2022) (3) |
| Nov 14, 2022 | 350 | REDACTED VERSION of 346 Letter, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 11/14/2022) (30) |
| Nov 10, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. [349] attachment Exhibits 1-8 have been replaced per counsels' request due to Exhibits being redacted. (vfm) |
| Nov 8, 2022 | 349 | Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [344] Letter, o The Honorable Christopher J. Burke from Ian R. Liston regarding Defendant's Letter Brief in Opposition to Plaintiffs' Motion for Leave to File Fourth Amended Complaint and to Reopen Fact Discovery by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Exhibit 1-8 REDACTED)(Liston, Ian) (Attachment 1 replaced on 11/10/2022) (vfm). |
| Nov 8, 2022 | 349 | Redacted Document (Exhibit 1-8 REDACTED) (30) Docket Text: REDACTED VERSION of [344] Letter, o The Honorable Christopher J. Burke from Ian R. Liston regarding Defendant's Letter Brief in Opposition to Plaintiffs' Motion for Leave to File Fourth Amended Complaint and to Reopen Fact Discovery by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Exhibit 1-8 REDACTED)(Liston, Ian) (Attachment 1 replaced on 11/10/2022) (vfm). |
| Nov 7, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: The Court, having reviewed the parties' November 4, 2022 letter requesting a teleconference regarding Plaintiffs' Motion for Leave to File Fourth Amended Complaint, (D.I. [347]), hereby ORDERS as follows: (1) A Telephone Conference to address the motion is set for 12/5/2022 at 02:00 PM before Judge Christopher J. Burke.; and (2) By no later than November 28, 2022, the parties shall jointly provide the Court's Law Clerk, Melanie Crawford, with a dial-in number via e-mail to use for the call. Ordered by Judge Christopher J. Burke on 11/7/22. (mlc) |
| Nov 4, 2022 | 345 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [338] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Exs. C-I)(Flynn, Michael) |
| Nov 4, 2022 | 345 | Redacted Document (Ex. A) (30) Docket Text: REDACTED VERSION of [338] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Exs. C-I)(Flynn, Michael) |
| Nov 4, 2022 | 345 | Redacted Document (Ex. B) (30) Docket Text: REDACTED VERSION of [338] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Exs. C-I)(Flynn, Michael) |
| Nov 4, 2022 | 345 | Redacted Document (Exs. C-I) (30) Docket Text: REDACTED VERSION of [338] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Ex. A, # (2) Ex. B, # (3) Exs. C-I)(Flynn, Michael) |
| Nov 4, 2022 | 347 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn regarding request for the scheduling of a teleconference - re [337] MOTION for Leave to File Fourth Amended Complaint. (Flynn, Michael) |
| Oct 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [342] STIPULATION TO EXTEND TIME to Submit Redactions to Plaintiffs' Motion for Leave to File Fourth Amended Complaint and Exhibits to November 4, 2022 filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter US LLC, Medinter Ltd UK. Ordered by Judge Christopher J. Burke on 10/28/22. (mlc) |
| Oct 28, 2022 | 341 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Opposition to Plaintiffs' Motion for Leave to File Fourth Amended Complaint to November 1, 2022 and Plaintiffs' Reply on November 4, 2022 - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Oct 28, 2022 | 342 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Redactions to Plaintiffs' Motion for Leave to File Fourth Amended Complaint and Exhibits to November 4, 2022 - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Oct 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [341] STIPULATION TO EXTEND TIME Opposition to Plaintiffs' Motion for Leave to File Fourth Amended Complaint to November 1, 2022 and Plaintiffs' Reply on November 4, 2022 filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter US LLC, Medinter Ltd UK. Signed by Judge Christopher J. Burke on 10/28/2022. (srs) Modified on 10/28/2022 (srs). |
| Oct 26, 2022 | 339 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of of the Opening Report of Dr. Sarah Heilshorn, Ph.D. filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Oct 26, 2022 | 340 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Prof. Christopher Bowman, Ph.D Regarding Infringement of U.S. Patent Nos. 6,716,251 and 7,731,758, (2) Opening Expert Report of Dr. John H. Joseph, M.D. and (3) Expert Report of Michael E. Tate filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Oct 21, 2022 | 336 | Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Elliot Choi as co-counsel. Reason for request: no longer with the firm. (Flynn, Michael) |
| Oct 21, 2022 | 337 | Motion for Leave to File (5) Docket Text: MOTION for Leave to File Fourth Amended Complaint - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Sep 27, 2022 | 335 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Aden Allen and Matt Blair as co-counsel. Reason for request: no longer with firm. (Liston, Ian) |
| Aug 30, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [334] Stipulation to Modify Case Schedule filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 8/30/2022. (dlb) |
| Aug 29, 2022 | 334 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Aug 16, 2022 | 333 | SO ORDERED (30) Docket Text: SO ORDERED, re [332] Stipulation of Dismissal as to Defendants Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LP (with prejudice), filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Joshua D. Wolson on 08/16/2022. (smg) |
| Aug 11, 2022 | 332 | Stipulation of Dismissal (Main Document) (2) Docket Text: STIPULATION of Dismissal as to Defendants Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LP (with prejudice) - by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Settlement Agreement)(Flynn, Michael) Modified on 8/11/2022 (dlb). |
| Aug 11, 2022 | 332 | Stipulation of Dismissal (Exhibit A) (30) Docket Text: STIPULATION of Dismissal as to Defendants Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LP (with prejudice) - by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Settlement Agreement)(Flynn, Michael) Modified on 8/11/2022 (dlb). |
| Aug 8, 2022 | 331 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Rule 26(a)(1) Supplemental Initial Disclosures, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Supplemental Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc's Interrogatory Nos. 1-5, 9, 14, 15, and 17, and (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Supplemental Objections and Response to Medinter US LLC, Medinter Ltd. (BVI), Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Interrogatory No. 7 - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Aug 3, 2022 | 330 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Defendants Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LP (with prejudice) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 22, 2022 | 329 | Redacted Document (8) Docket Text: REDACTED VERSION of [327] MOTION for Addendum to Letters of Request (Unopposed) re [298] Amended MOTION for Issuance of Letters Rogatory (Unopposed) re: D.I. 242 Amended MOTION for Issuance of Letters Rogatory (Unopposed) by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 6, 2022 | 326 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Angel Barraza on August 5, 2022 filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Jun 22, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Joshua D. Wolson - Status Conference via Zoom held on 6/22/2022. (nmg) |
| Jun 21, 2022 | 325 | Order (1) Docket Text: ORDER, the Zoom status conference scheduled for June 22, 2022 will take place at 4:00 p.m. EDT. Signed by Judge Joshua D. Wolson on 06/21/2022. (smg) |
| Jun 9, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [324] Stipulation filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 6/9/2022. (dlb) |
| Jun 8, 2022 | 323 | Order (1) Docket Text: ORDER, A Zoom status conference is scheduled for June 22, 2022 at 2:00 p.m. ET, before the undersigned. The Court will provide the Parties with the Zoom link closer to the scheduled date. Signed by Judge Joshua D. Wolson on 6/8/2022. (apk) |
| Jun 8, 2022 | 324 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jun 6, 2022 | 320 | Order on Motion for Issuance of Letters Rogatory (2) Docket Text: ORDER granting [311] Motion for Issuance of Letters Rogatory. (See Order for further details) Signed by Judge Joshua D. Wolson on 06/06/2022. (smg) |
| Jun 6, 2022 | 321 | Order (30) Docket Text: ORDER Granting Galderma's Motion for Issuance of Request for International Judicial Assistance. Signed by Judge Joshua D. Wolson on 06/06/2022.(A certified copy will be available for pick-up at the Clerk's Office) (smg) |
| Jun 6, 2022 | 322 | Redacted Document (19) Docket Text: REDACTED VERSION of [318] Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jun 2, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Joshua D. Wolson of the United States District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (JDW) after the case number on all documents filed. (rjb) |
| Jun 2, 2022 | 319 | Order (1) Docket Text: ORDER: DESIGNATION OF DISTRICT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Joshua D. Wolson of the United States District Court for the Eastern District of Pennsylvania. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 6/2/2022. (rjb) |
| May 18, 2022 | 317 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity Contentions re SO ORDERED, filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| May 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [315] STIPULATION TO EXTEND TIME to Serve Defendants' Final Invalidity Contentions to May 17, 2022 filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter US LLC, Medinter Ltd UK. Ordered by Judge Christopher J. Burke on 5/16/2022. (dlb) |
| May 17, 2022 | 316 | Answering Brief in Opposition (4) Docket Text: ANSWERING BRIEF in Opposition re [311] MOTION for Issuance of Letters Rogatory (Motion for Issuance of Requests for International Judicial Assistance and Memorandum of Law in support thereof) filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.Reply Brief due date per Local Rules is 5/24/2022. (Liston, Ian) |
| May 16, 2022 | 315 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Final Invalidity Contentions to May 17, 2022 - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| May 11, 2022 | 314 | Redacted Document (Main Document) (9) Docket Text: REDACTED VERSION of [311] MOTION for Issuance of Letters Rogatory (Motion for Issuance of Requests for International Judicial Assistance and Memorandum of Law in support thereof) - by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exs. A-B)(Flynn, Michael) |
| May 11, 2022 | 314 | Redacted Document (Exs. A-B) (30) Docket Text: REDACTED VERSION of [311] MOTION for Issuance of Letters Rogatory (Motion for Issuance of Requests for International Judicial Assistance and Memorandum of Law in support thereof) - by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exs. A-B)(Flynn, Michael) |
| May 4, 2022 | 313 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc.'s Fifth Set of Requests for Production - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| May 3, 2022 | 312 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Dr. Susan Weinkle's Supplemental Objections and Responses to Medinter's Subpoena to Produce Documents and Things in a Civil Action - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Apr 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [310] MOTION for Pro Hac Vice Appearance of Attorney Cecilia G. Rambarat, filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Colm F. Connolly on 4/27/2022. (kmd) |
| Apr 26, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [309] Stipulation extending Certain Scheduling Order Deadlines filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 4/26/2022. (dlb) |
| Apr 26, 2022 | 309 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 26, 2022 | 310 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Cecilia G. Rambarat - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Apr 25, 2022 | 308 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Final Infringement Contentions filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Apr 19, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [307] STIPULATION TO EXTEND TIME for Plaintiffs to serve Final Infringement Contentions to April 25, 2022 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 4/19/2022. (mlc) |
| Apr 18, 2022 | 307 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to serve Final Infringement Contentions to April 25, 2022 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 14, 2022 | 306 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Dr. Susan Weinkle's Objections and Responses to Medinter's Subpoena to Produce Documents and Things in a Civil Action - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Apr 6, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Hall for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (ceg) |
| Apr 5, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Amended NOTICE of Subpoena (John LaRosa), filed by Galderma Laboratories, L.P., Galderma S.A. on 4/5/2022, has been removed per counsel's request. The Notice will be re-filed shortly. (kmd) |
| Apr 5, 2022 | 304 | Notice (Other) (7) Docket Text: Amended NOTICE of Subpoena (John LaRosa) - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Apr 5, 2022 | 305 | Notice (Other) (7) Docket Text: Amended NOTICE of Subpoena (Keith Greathouse) - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Apr 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [298] Amended MOTION for Issuance of Letters Rogatory (Unopposed) re: D.I. 242 Amended MOTION for Issuance of Letters Rogatory (Unopposed) filed by Galderma S.A., Galderma Laboratories, L.P.. Ordered by Judge Christopher J. Burke on 4/4/2022. (dlb) |
| Apr 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Edward Powell, III for Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dennis D. Gregory for Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, and Medinter US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 4, 2022 | N/A | Remark (0) Docket Text: Remark: Per the Court's granting of the[SEALED] Amended MOTION for Issuance of Letters Rogatory (Unopposed), a Deputy Clerk has, on this date, prepared and return the signed letters to Plaintiff for transmittal to the appropriate diplomatic authorities. (dlb) |
| Apr 4, 2022 | 303 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Supplemental Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc.'s Interrogatory Nos. 1, 2, 14, 15, and 17 - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Apr 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [300] MOTION for Pro Hac Vice Appearance of Attorney G. Edward Powell, III and Dennis Gregory, filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter US LLC, Medinter Ltd UK. Ordered by Judge Colm F. Connolly on 4/1/2022. (kmd) |
| Apr 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [302] MOTION for Pro Hac Vice Appearance of Attorney Ryan P. Regan, filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Colm F. Connolly on 4/1/2022. (kmd) |
| Apr 1, 2022 | 301 | Redacted Document (30) Docket Text: REDACTED VERSION of [298] Amended MOTION for Issuance of Letters Rogatory (Unopposed) re: D.I. 242 Amended MOTION for Issuance of Letters Rogatory (Unopposed) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 1, 2022 | 302 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan P. Regan - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Mar 30, 2022 | 300 | Motion for Leave to Appear Pro Hac Vice (Main Document) (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney G. Edward Powell, III and Dennis Gregory - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Certification of G. Edward Powell, III, # (2) Certification of Dennis Gregory)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Mar 30, 2022 | 300 | Motion for Leave to Appear Pro Hac Vice (Certification of G. Edward Powell, III) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney G. Edward Powell, III and Dennis Gregory - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Certification of G. Edward Powell, III, # (2) Certification of Dennis Gregory)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Mar 30, 2022 | 300 | Motion for Leave to Appear Pro Hac Vice (Certification of Dennis Gregory) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney G. Edward Powell, III and Dennis Gregory - filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Certification of G. Edward Powell, III, # (2) Certification of Dennis Gregory)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Mar 28, 2022 | 299 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc.'s Second Set of Requests for Admission, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc.'s Fourth Set of Requests for Production and (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd. BVI, Medinter Ltd. UK, and Medgraft Microtech, Inc's Fourth Set of Interrogatories - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Mar 25, 2022 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED: [298] Amended MOTION for Issuance of Letters Rogatory (Unopposed) re: D.I. 242 Amended MOTION for Issuance of Letters Rogatory (Unopposed) Motion referred to Magistrate Judge Christopher J. Burke.(nmf) |
| Mar 24, 2022 | 297 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendant Medinter Medinter, Ltd. (BVI)s Objections and Responses to Plaintiffs Fourth Set of Requests for Production Nos. 1-46; (ii) Defendants Medinter US LLC, Medinter Ltd. (UK), Medinter, Ltd. (BVI), and Medgraft Microtech, Inc.s Objections and Responses to Plaintiffs Request for Inspection; and (iii) Defendants Medinter US LLC, Medinter Ltd. (UK), Medinter, Ltd. (BVI), and Medgraft Microtech, Inc.s Fifth Set of Requests for Production Upon Galderma Laboroatories, L.P. and Galderma S.A. filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Mar 23, 2022 | 295 | Notice (Other) (7) Docket Text: NOTICE of Subpoena to Testify at a Deposition to Dr. Susan Weinkle by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC (Liston, Ian) |
| Mar 23, 2022 | 296 | Notice (Other) (26) Docket Text: NOTICE of Subpoena to Produce Documents to Dr. Susan Weinkle by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC (Liston, Ian) |
| Mar 22, 2022 | 294 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Carrie Caulkins Pursuant to Fed. R. Civ P.30(b)(1) on March 29, 2022 filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Mar 16, 2022 | 292 | Redacted Document (15) Docket Text: REDACTED VERSION of [288] Notice to Take Deposition (Medinter) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Mar 16, 2022 | 293 | Redacted Document (15) Docket Text: REDACTED VERSION of [290] Notice to Take Deposition (Medgraft) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Mar 15, 2022 | 291 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Fourth Set of Requests for Production of Documents and Things Propounded Upon Medinter Ltd. BVI - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Mar 10, 2022 | 289 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Medinter US LLC, Medinter Ltd. (UK), Medinter, Ltd. (BVI) and Medgraft Microtech, Inc.'s Objections and Responses to Galderma's Requests for Admissions Nos. 1-16 filed by Medgraft Microtech, Inc., Medinter Ltd BVI, Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Mar 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [287] Stipulation filed by Galderma S.A., Galderma Laboratories, L.P. See Stipulation for details. ( Discovery due by 4/29/2022, Opening Expert Reports due by 5/25/2022, Rebuttal Expert Reports due by 6/22/2022, Dispositive Motions due by 8/17/2022.) Ordered by Judge Christopher J. Burke on 3/3/2022. (dlb) |
| Mar 3, 2022 | 287 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Feb 23, 2022 | 286 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Requests for Inspection Propounded Upon Defendants Medinter US LLC, Medinter Ltd. UK, Medinter Ltd. BVI, and Medgraft Microtech, Inc. - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Feb 8, 2022 | 285 | Notice (Other) (8) Docket Text: NOTICE of Subpoena (Steven Kumbier) - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Feb 2, 2022 | 284 | Redacted Document (30) Docket Text: REDACTED VERSION of [283] Answer to Amended Complaint by Medinter Ltd BVI. (Liston, Ian) |
| Jan 24, 2022 | 282 | SO ORDERED (2) Docket Text: SO ORDERED granting D.I. [281] Joint MOTION for Issuance of Letters Rogatory for Issuance of Addendum to Exemplification Certificate in Relation to Plaintiffs Letter of Request filed by Medgraft Microtech, Inc., Medinter US LLC, Medinter Ltd UK. Signed by Judge Christopher J. Burke on 1/24/2022. (dlb) |
| Jan 21, 2022 | 281 | Motion for Issuance of Letters Rogatory (Main Document) (3) Docket Text: Joint MOTION for Issuance of Letters Rogatory for Issuance of Addendum to Exemplification Certificate in Relation to Plaintiffs Letter of Request - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Addendum to Exemplification Certificate)(Liston, Ian) |
| Jan 21, 2022 | 281 | Motion for Issuance of Letters Rogatory (Addendum to Exemplification Certificate) (2) Docket Text: Joint MOTION for Issuance of Letters Rogatory for Issuance of Addendum to Exemplification Certificate in Relation to Plaintiffs Letter of Request - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Addendum to Exemplification Certificate)(Liston, Ian) |
| Jan 14, 2022 | 279 | Redacted Document (30) Docket Text: REDACTED VERSION of [260] Answer to Complaint by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Jan 14, 2022 | 280 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Responses to Plaintiffs' Third Set of Requests for Production of Documents and Things (Nos. 36-41); and (ii) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Objections and Responses to Plaintiffs' Fourth Set of Interrogatories (Nos. 21-23) filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Jan 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [278] MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer, filed by Medgraft Microtech, Inc., Medinter US LLC, Medinter Ltd UK. Ordered by Judge Colm F. Connolly on 1/13/2022. (kmd) |
| Jan 13, 2022 | 278 | Motion for Leave to Appear Pro Hac Vice (Main Document) (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Certification of David S. Steuer)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Jan 13, 2022 | 278 | Motion for Leave to Appear Pro Hac Vice (Certification of David S. Steuer) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Certification of David S. Steuer)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Jan 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' January 11, 2022 joint status report, (D.I. 276), hereby ORDERS as follows: (1) The Medinter Defendants' Motion for a Protective Order, (D.I. 274), is DENIED AS MOOT; and (2) With respect to the Medinter Defendants' anticipated revised Motion for a Protective Order, if they choose to file such a motion, the Medinter Defendants should file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues, as well as an accompanying "Motion for Protective Order." The Medinter Defendants should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (3) If the motion is filed, the Court will set a further briefing schedule thereafter. Ordered by Judge Christopher J. Burke on 1/12/2022. (lih) |
| Jan 11, 2022 | 276 | Status Report (2) Docket Text: Joint STATUS REPORT re: Defendants' Motion for Protective Order (D.I. 274) and the Court's Oral Order of January 10, 2022 (D.I. 275) by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Jan 10, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendants' Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Motion for a Protective Order ("the Motion"), (D.I. [274]), hereby ORDERS that by no later than January 11, 2022, the parties shall file a joint status report of no longer than 2 single-spaced pages that indicates: (1) whether the deposition of Jung Jiunn Der occurred; and (2) whether any part of the current request for relief is moot, and otherwise, what relief is currently being requested, if any. The Court will then determine whether a further briefing schedule is necessary. Ordered by Judge Christopher J. Burke on 1/10/2022. (ceg) |
| Jan 7, 2022 | 274 | Motion for Protective Order (Main Document) (3) Docket Text: MOTION for Protective Order under Fed. R. Civ. P. 26(c)(1)(B), 30, and 32 and Delaware L.R. 30.1 - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Exhibits 1 through 3, # (2) Proposed Order)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Jan 7, 2022 | 274 | Motion for Protective Order (Exhibits 1 through 3) (9) Docket Text: MOTION for Protective Order under Fed. R. Civ. P. 26(c)(1)(B), 30, and 32 and Delaware L.R. 30.1 - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Exhibits 1 through 3, # (2) Proposed Order)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Jan 7, 2022 | 274 | Motion for Protective Order (Proposed Order) (1) Docket Text: MOTION for Protective Order under Fed. R. Civ. P. 26(c)(1)(B), 30, and 32 and Delaware L.R. 30.1 - filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Attachments: # (1) Exhibits 1 through 3, # (2) Proposed Order)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Jan 6, 2022 | 272 | Redacted Document (Main Document) (28) Docket Text: REDACTED VERSION of [252] Amended Complaint, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-M)(Flynn, Michael) |
| Jan 6, 2022 | 272 | Redacted Document (Exhibits A-M) (30) Docket Text: REDACTED VERSION of [252] Amended Complaint, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-M)(Flynn, Michael) |
| Jan 6, 2022 | 273 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Jung Jiunn Der on January 10, 2022 filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Jan 5, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [268] Stipulation to modify case schedule filed by Galderma S.A., Galderma Laboratories, L.P., Set/Reset Scheduling Order Deadlines: ( Discovery due by 3/30/2022., Opening Expert Reports due by 4/27/2022., Dispositive Motions due by 7/20/2022. See stipulation for further deadlines. Ordered by Judge Christopher J. Burke on 1/5/2022. (mlc) |
| Jan 5, 2022 | 269 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendants Medinter US LLC and Medinter Ltd. (UK)'s Supplemental Responses to Plaintiffs' First Set of Interrogatories Nos. 2 and 6; (ii) Defendant Medgraft Microtech, Inc.'s Supplemental Responses to Plaintiffs' First Set of Interrogatories Nos. 2 and 6; and (iii) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc's Objections and Responses to Galderma's Requests for Admission Nos. 1-16 re [266] Notice of Service,, filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Jan 5, 2022 | 270 | Affidavit of Service (1) Docket Text: AFFIDAVIT of Service for Summons in a Civil Action; Third Amended Complaint with Exhibits served on Medinter Ltd. BVI on 01/05/2022, filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jan 5, 2022 | 271 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jennifer A. Ward on behalf of Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC (Ward, Jennifer) |
| Jan 4, 2022 | 267 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech Inc.'s Objections and Responses to Plaintiffs' Third Set of Interrogatories Nos. 18-20; and (ii) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Final Supplement to the Identification of Invalidity References filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Jan 4, 2022 | 268 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 30, 2021 | 266 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendants Medinter US LLC and Medinter Ltd. (UK)'s Supplemental Responses to Plaintiffs' First Set of Interrogatories Nos. 2 and 6; (ii) Defendant Medgraft Microtech, Inc.'s Supplemental Responses to Plaintiffs' First Set of Interrogatories Nos. 2 and 6; and (iii) Defendants Medinter US LLC, Medinter Ltd. (UK), and Medgraft Microtech, Inc.'s Objections and Responses to Galderma's Requests for Admission Nos. 1-16 filed by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC.(Liston, Ian) |
| Dec 20, 2021 | 265 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Final Supplement to the Identification of the Accused Products filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Dec 15, 2021 | 262 | Redacted Document (10) Docket Text: REDACTED VERSION of [256] Notice (Other) Subpoena to Testify at a Deposition to DermAvance Pharmaceuticals, Inc. by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Dec 15, 2021 | 263 | Redacted Document (24) Docket Text: REDACTED VERSION of [257] Notice (Other) of Subpoena to Produce Documents, to DermAvance Pharmaceuticals, Inc. by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC. (Liston, Ian) |
| Dec 15, 2021 | 264 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Interrogatories 21-23 to Medinter US LLC, Medinter LTD. UK, Medinter LTD. BVI, and Medgraft Microtech, Inc. and (2) Galderma Laboratories, L.P. and Galderma S.A.'s Second Set of Requests for Production of Documents and Things Propounded Upon Medinter US LLC, Medinter LTD. UK, Medinter LTD. BVI and Medgraft Microtech, Inc. - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Dec 14, 2021 | 259 | Redacted Document (27) Docket Text: REDACTED VERSION of [258] Notice (Other) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 14, 2021 | 261 | Answer to Complaint (7) Docket Text: ANSWER to Complaint and Affirmative Defenses to Plaintiffs' Third Amended Complaint by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Dec 10, 2021 | 253 | Notice (Other) (6) Docket Text: NOTICE of Subpoena to Testify at a Deposition to John Larosa by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC (Liston, Ian) |
| Dec 10, 2021 | 254 | Notice (Other) (6) Docket Text: NOTICE of Subpoena to Testify at a Deposition to Keith Greathouse by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC (Liston, Ian) |
| Dec 10, 2021 | 255 | Notice (Other) (24) Docket Text: NOTICE of Subpoena to Produce Documents to Keith Greathouse by Medgraft Microtech, Inc., Medinter Ltd UK, Medinter US LLC (Liston, Ian) |
| Nov 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [248] MOTION for Leave to File Third Amended Complaint re [245] Letter Brief in Support filed by Galderma S.A., Galderma Laboratories, L.P. as no opposition has been timely filed. Counsel for Plaintiffs shall file the Third Amended Complaint on the docket by close of business today. Ordered by Judge Christopher J. Burke on 11/30/2021. (dlb) |
| Nov 30, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court ORDERS that Plaintiffs shall file the Third Amended Complaint by no later than close of business today. Ordered by Judge Christopher J. Burke on 11/30/2021. (dlb) |
| Nov 29, 2021 | 250 | Statement (2) Docket Text: STATEMENT re [248] MOTION for Leave to File Third Amended Complaint re [245] Letter Brief in Support Statement of Non-Opposition to Plaintiffs' Motion for Leave to File Third Amended Complaint by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Nov 22, 2021 | 249 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Interrogatories 18-20 to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Nov 19, 2021 | 246 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Requests for Admission Nos. 1-16 Propounded Upon Defendants Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Nov 19, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Plaintiffs' letter brief in support of a motion for leave to file a Third Amended Complaint, (D.I. 245), notes that Plaintiffs did not file an accompanying motion. For the Court's administrative purposes, Plaintiffs shall file such a motion by no later than November 19, 2021. Ordered by Judge Christopher J. Burke on 11/19/2021. (dlb) |
| Nov 19, 2021 | 248 | Motion for Leave to File (4) Docket Text: MOTION for Leave to File Third Amended Complaint re [245] Letter Brief in Support - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Nov 18, 2021 | 244 | Redacted Document (30) Docket Text: REDACTED VERSION of [242] Amended MOTION for Issuance of Letters Rogatory (Unopposed) by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Nov 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [243] MOTION for Pro Hac Vice Appearance of Attorney Elliot Choi, filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Colm F. Connolly on 11/17/2021. (kmd) |
| Nov 16, 2021 | 243 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elliot Choi - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Nov 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [242] Amended MOTION for Issuance of Letters Rogatory (Unopposed) filed by Galderma S.A., Galderma Laboratories, L.P.. Ordered by Judge Christopher J. Burke on 11/8/2021. (dlb) |
| Nov 9, 2021 | N/A | Remark (0) Docket Text: Remark: Per the Court's granting of the SEALED Motion for Issuance of Letters of Request, a Deputy Clerk has, on this date, prepared and return the signed letters to Plaintiff for transmittal to the appropriate diplomatic authorities. (dlb) |
| Nov 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I., re [241] Stipulation to Modify Case Schedule filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 11/3/2021. (dlb) |
| Nov 2, 2021 | 241 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedule by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Nov 1, 2021 | 239 | Notice (Other) (24) Docket Text: NOTICE of Subpoena to Purac America Inc. to Produce Documents - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Nov 1, 2021 | 240 | Notice (Other) (10) Docket Text: NOTICE of Subpoena to Testify at a Deposition to Purac America Inc. - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Oct 28, 2021 | 237 | Notice (Other) (24) Docket Text: NOTICE of Subpoena to Produce Documents (Purac America Inc.) - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Oct 28, 2021 | 238 | Notice (Other) (10) Docket Text: NOTICE of Subpoena to Testify at a Deposition (Purac America Inc.) - by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Oct 5, 2021 | 234 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Responses to Notice of 30(b)(6) Deposition filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Sep 22, 2021 | 231 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Raymond Canaris on October 19, 2021 filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Sep 10, 2021 | 230 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Angel Barraza on October 20, 2021 filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Aug 31, 2021 | 229 | Redacted Document (15) Docket Text: REDACTED VERSION of [228] Notice to Take Deposition - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 27, 2021 | 227 | Memorandum and Order (7) Docket Text: MEMORANDUM ORDER re: claim construction Signed by Judge Colm F. Connolly on 7/27/2021. (nmf) |
| Jul 22, 2021 | 225 | Notice (Other) (Main Document) (4) Docket Text: NOTICE of Lodging by Galderma Laboratories, L.P., Galderma S.A. re Evidentiary Hearing (Attachments: # (1) Exhibit A)(Flynn, Michael) |
| Jul 22, 2021 | 225 | Notice (Other) (Exhibit A) (30) Docket Text: NOTICE of Lodging by Galderma Laboratories, L.P., Galderma S.A. re Evidentiary Hearing (Attachments: # (1) Exhibit A)(Flynn, Michael) |
| Jul 22, 2021 | 226 | Notice (Other) (Main Document) (2) Docket Text: NOTICE of Lodging by Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.of Demostratives Used at Evidentiary Hearing by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC (Attachments: # (1) Exhibits A through E)(Liston, Ian) |
| Jul 22, 2021 | 226 | Notice (Other) (Exhibits A through E) (30) Docket Text: NOTICE of Lodging by Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.of Demostratives Used at Evidentiary Hearing by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC (Attachments: # (1) Exhibits A through E)(Liston, Ian) |
| Jul 16, 2021 | 224 | Order (3) Docket Text: SUPPLEMENTAL CLAIM CONSTRUCTION ORDER Signed by Judge Colm F. Connolly on 7/16/2021. (nmf) |
| Jul 15, 2021 | 223 | Proposed Order (3) Docket Text: PROPOSED ORDER -- [Proposed] Supplemental Claim Construction Order -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 6, 2021 | N/A | Evidentiary Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Evidentiary Hearing held on 7/6/2021. (Court Reporter V. Gunning.) Counsel to submit a proposed order to the Court on or before July 15, 2021. (nmf) |
| May 28, 2021 | 222 | Redacted Document (30) Docket Text: REDACTED VERSION of [219] MOTION for Issuance of Letters Rogatory (Unopposed) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| May 19, 2021 | 221 | SO ORDERED (3) Docket Text: SO ORDERED D.I. [220] Stipulation to Amend Schedule filed by Galderma S.A., Galderma Laboratories, L.P., ORDER, Setting Scheduling Order Deadlines ( Discovery due by 11/18/2021., Dispositive Motions due by 3/21/2022. Pretrial conference date to be determined. Trial date to be determined. See Stipulation and Order for further deadlines.). Signed by Judge Christopher J. Burke on 5/19/2021. (mlc) |
| May 18, 2021 | N/A | Remark (0) Docket Text: Remark: Per the Court's granting of the SEALED Motion for Issuance of Letters of Request, a Deputy Clerk has, on this date, prepared and return the signed letters to Plaintiff for transmittal to the appropriate diplomatic authorities. (dlb) |
| May 18, 2021 | 220 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend Schedule - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| May 14, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [219] MOTION for Issuance of Letters Rogatory (Unopposed) filed by Galderma S.A., Galderma Laboratories, L.P.. Signed by Judge Christopher J. Burke on 5/14/2021. (dlb) |
| May 7, 2021 | 218 | Notice (Other) (2) Docket Text: NOTICE of Withdrawl of the Appearance of Diyang Liu by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC re Add Attorneys Pro Hac Vice, (Liston, Ian) |
| Apr 27, 2021 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Evidentiary Hearing is rescheduled per request of counsel for 7/6/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Apr 14, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court shall hear oral argument and expert testimony with respect to the outstanding claim construction issues in Courtroom 4B on May 11, 2021 at 9:00 a.m. Ordered by Judge Colm F. Connolly on 4/14/2021. (nmf) |
| Mar 24, 2021 | N/A | Notice of Filing Multi Media Materials (0) Docket Text: NOTICE of filing the following Non-Paper material(s) in multi media format: video attachments. Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Galderma Laboratories, L.P., Galderma S.A. (SEE D.I. [216]) (fms) |
| Mar 24, 2021 | N/A | Multi Media Document (0) Docket Text: [SEALED] MULTI MEDIA DOCUMENT in the form of a CD Rom. Filing related to [215] Appendix. Video Attachments to Exhibit 31. (Media on file in Clerk's Office). (fms) |
| Mar 23, 2021 | 213 | Notice (Other) (3) Docket Text: NOTICE of Service of Defendants' Rebuttal Supplemental Claim Construction Brief and Rebuttal Declarations of Sarah Heilshorn, Ph.D. and Stephen Spiegelberg, Ph.D. by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC (Liston, Ian) |
| Mar 23, 2021 | 216 | Notice (Other) (4) Docket Text: NOTICE of Lodging video attachments by Galderma Laboratories, L.P., Galderma S.A. (Moshos, Andrew) |
| Mar 22, 2021 | 212 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Answering Supplemental Claims Construction Brief, (2) Declaration Of Joseph A. Mahoney and (3) Answering Declaration of Jennifer H. Elisseeff, Ph.D. - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Mar 17, 2021 | 211 | SO ORDERED (2) Docket Text: SO ORDERED, re [210] STIPULATION TO EXTEND TIME for (1) Simultaneous exchange of rebuttal claim construction supplemental submissions and (2) Joint submission to Court to March 22, 2021 and March 23, 2021, respectively filed by Galderma S.A., Galderma Laboratories, L.P. Oral Argument date to be determined (if requested by the Court). Signed by Judge Colm F. Connolly on 3/17/2021. (fms) |
| Mar 16, 2021 | 210 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for (1) Simultaneous exchange of rebuttal claim construction supplemental submissions and (2) Joint submission to Court to March 22, 2021 and March 23, 2021, respectively - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Feb 25, 2021 | 209 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants Medinter US LLC, Medinter LTD., and Medgraft Microtech, Inc.'s Supplemental Claim Construction Brief; (2) Expert Declaration of Stephen Spielberg, Ph.D., and (3) Expert Declaration of Sarah Heilshorn, Ph.D. filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Feb 24, 2021 | 208 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Opening Supplemental Claims Construction Submissions and (2) Declaration of Joseph A. Mahoney - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Feb 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [207] STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges to February 24, 2021 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. Signed by Judge Colm F. Connolly on 2/22/2021. (fms) |
| Feb 19, 2021 | 207 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges to February 24, 2021 - filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Feb 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [206] STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges to February 22, 2021 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. Signed by Judge Colm F. Connolly on 2/16/2021. (fms) |
| Feb 15, 2021 | 206 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges to February 22, 2021 - filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Jan 22, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If the Court decides oral argument or an evidentiary hearing is necessary to decide the pending claim construction issues, it will hear argument and/or testimony by videoconference on March 31, 2021 at 10:00 a.m. The parties shall jointly make the necessary arrangements for the videoconferencing. Ordered by Judge Colm F. Connolly on 1/22/2021. (nmf) |
| Jan 21, 2021 | 204 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges and joint submission to various dates - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jan 21, 2021 | 205 | SO ORDERED (2) Docket Text: SO ORDERED, re [204] STIPULATION TO EXTEND TIME for the parties' supplemental claim construction exchanges and joint submission to various dates filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Colm F. Connolly on 1/21/2021. (nmf) |
| Jan 13, 2021 | 203 | Order (2) Docket Text: ORDER granting [199] Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] filed by Galderma S.A., Galderma Laboratories, L.P., Party DermAvance Pharmaceuticals, Inc. terminated. Signed by Judge Colm F. Connolly on 1/13/2021. (nmf) |
| Jan 12, 2021 | 202 | Reply Brief (4) Docket Text: REPLY BRIEF re [199] Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] filed by DermAvance Pharmaceuticals, Inc.. (Higgins, James) |
| Jan 11, 2021 | 200 | Response to Motion (5) Docket Text: RESPONSE to Motion re [199] Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Jan 11, 2021 | 201 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Defendant Medgraft Microtech, Inc.s Responses to Plaintiffs Second Set of Interrogatories Nos. 16-17; (ii) Defendants Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s Responses to Plaintiffs Second Set of Requests for Production, Nos. 31-35; and (iii) Defendants Medinter US LLC and Medinter Ltd.s Responses to Plaintiffs Second Set of Interrogatories Nos. 16-17 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Jan 5, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER - The SO ORDERED of [199] Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] filed by Galderma S.A., Galderma Laboratories, L.P. dated 1/4/2021 has been VACATED. Any opposition to D.I. [199] must be filed by Monday, 1/11/2021. Ordered by Judge Colm F. Connolly on 1/5/2021. (fms) |
| Jan 4, 2021 | N/A | SO ORDERED (0) Docket Text: (VACATED - SEE ORAL ORDER OF 1/5/2021) SO ORDERED, re [199] Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] filed by Galderma S.A., Galderma Laboratories, L.P. Party DermAvance Pharmaceuticals, Inc. terminated. Ordered by Judge Colm F. Connolly on 1/4/2021. (fms) Modified on 1/5/2021 (fms). |
| Dec 30, 2020 | 199 | Motion to Dismiss (Main Document) (3) Docket Text: Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Text of Proposed Order)(Flynn, Michael) |
| Dec 30, 2020 | 199 | Motion to Dismiss (Text of Proposed Order) (2) Docket Text: Joint MOTION to Dismiss Based upon Federal Rule of Civil Procedure 41(a)(2) [with Prejudice] - filed by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Text of Proposed Order)(Flynn, Michael) |
| Dec 17, 2020 | 196 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal of DermAvance Pharmaceuticals, Inc. by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 17, 2020 | 197 | SO ORDERED (4) Docket Text: SO ORDERED, re [194] STIPULATION and Order to Amend Scheduling Order re [87] Scheduling Order,SCHEDULING ORDER: ( Discovery due by 7/19/2021., Expert Discovery due by 10/18/2021., Dispositive Motions and Opening Briefs due by 11/18/2021., A Final Pretrial Conference is set for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., A Jury Trial is set for 4/18/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.)Signed by Judge Colm F. Connolly on 12/17/2020. (nmf) |
| Dec 17, 2020 | 198 | Objections (4) Docket Text: OBJECTIONS by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC to [196] Stipulation of Dismissal . (Liston, Ian) |
| Dec 16, 2020 | 194 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Amend Scheduling Order re [87] Scheduling Order,, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 16, 2020 | 195 | Claim Construction Chart (13) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 15, 2020 | 193 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Medinter US LLC and Medinter Ltd.'s Responses and Objections to DermAvance Pharamaceuticals, Inc.'s First Set of Interrogatories, Nos 1-4; First Set of Requests for Admission, Nos. 1-5; and First Set of Requests for Production, Nos. 1-7 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Dec 4, 2020 | 191 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Second Set of Requests for Production of Documents and Things Propounded Upon Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Dec 4, 2020 | 192 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Second Set of Interrogatories Propounded Upon Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Dec 1, 2020 | 190 | Order (4) Docket Text: CLAIM CONSTRUCTION ORDER re [189] PROPOSED ORDER - [Proposed] Claim Construction Order. Signed by Judge Colm F. Connolly on 12/1/2020. (nmf) |
| Nov 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [188] STIPULATION TO EXTEND TIME to File Proposed Claim Construction Order to November 30, 2020 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC Signed by Judge Colm F. Connolly on 11/30/2020. (fms) |
| Nov 30, 2020 | 189 | Proposed Order (4) Docket Text: PROPOSED ORDER -- [Proposed] Claim Construction Order -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Nov 29, 2020 | 188 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to File Proposed Claim Construction Order to November 30, 2020 - filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Nov 20, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 11/20/2020. (Court Reporter V. Gunning.) (nmf) |
| Nov 19, 2020 | 185 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals' First Amended Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things filed by DermAvance Pharmaceuticals, Inc..(Lee, Steven) |
| Nov 19, 2020 | 186 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Ronald P. Golden, III on behalf of Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP (Golden, Ronald) |
| Nov 19, 2020 | 187 | Letter (2) Docket Text: Joint Letter to The Honorable Colm F. Connolly from Michael J. Flynn regarding Markman Hearing. (Flynn, Michael) |
| Nov 16, 2020 | 183 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals Inc.'s Objections and Responses to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.'s First Set of Requests for Production and DermAvance Pharmaceuticals Inc.'s Objections and Responses to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.'s First Set of Interrogatories filed by DermAvance Pharmaceuticals, Inc..(Lee, Steven) |
| Nov 16, 2020 | 184 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.'s First Set of Requests for Admission, (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.'s Third Set of Requests for Production and (3) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.'s Third Set of Interrogatories filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Nov 13, 2020 | 182 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) DermAvance Pharmaceuticals, Inc.'s First Set of Requests for Admission to Medinter US LLC and Medinter Ltd., (2) DermAvance Pharmaceuticals, Inc.'s First Set of Requests for Production to Medinter US LLC and Medinter Ltd. and (3) DermAvance Pharmaceuticals, Inc.'s First Set of Interrogatories to Medinter US LLC and Medinter Ltd. filed by DermAvance Pharmaceuticals, Inc..(Lee, Steven) |
| Oct 30, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Exhibit A has been added at D.I. 179 per request of filer. (dlb) |
| Oct 30, 2020 | 180 | SO ORDERED (3) Docket Text: SO ORDERED, re [178] Stipulation filed by Galderma S.A., Galderma Laboratories, L.P., ORDER, Setting Scheduling Order Deadlines ( Discovery due by 3/19/2021., Dispositive Motions due by 6/18/2021.) Signed by Judge Colm F. Connolly on 10/30/2020. (nmf) |
| Oct 29, 2020 | 178 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend Schedule (D.I. 87) - by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Oct 29, 2020 | 179 | Letter (Main Document) (2) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn regarding Joint Interim Status Report. (Flynn, Michael) (Additional attachment(s) added on 10/30/2020: # (1) Exhibit A) (dlb). |
| Oct 29, 2020 | 179 | Letter (Exhibit A) (15) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn regarding Joint Interim Status Report. (Flynn, Michael) (Additional attachment(s) added on 10/30/2020: # (1) Exhibit A) (dlb). |
| Oct 28, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Hearings: The Markman Hearing set for 11/20/2020 at 09:00 AM before Judge Colm F. Connolly will be held by telephone. Counsel shall coordinate the call and email the dial-in information to chambers. The parties may also email to chambers any slides they would like to present no later than 24 hours in advance of the hearing. Ordered by Judge Colm F. Connolly on 10/28/2020. (nmf) |
| Oct 28, 2020 | 176 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals' Third Amended Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Oct 28, 2020 | 177 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) DermAvance's First Set of Requests for Admission to Galderma, (2) DermAvance's First Set of Requests for Production to Galderma, and (3) DermAvance's First Set of Interrogatories to Galderma filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Oct 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [174] STIPULATION TO EXTEND TIME for the parties to submit an Interim Status Report to October 29, 2020 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 10/23/2020. (dlb) |
| Oct 22, 2020 | 174 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit an Interim Status Report to October 29, 2020 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Main Document) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Ex. 1) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Ex. 2) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Ex. 3) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Exs. 4-11) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Ex. 12 (Physical sample provided to Court)) (1) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 22, 2020 | 175 | Joint Claim Construction Brief (Exs. 13-15) (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Ex. 1, # (2) Ex. 2, # (3) Ex. 3, # (4) Exs. 4-11, # (5) Ex. 12 (Physical sample provided to Court), # (6) Exs. 13-15)(Flynn, Michael) |
| Oct 20, 2020 | 173 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Supplemental Response to Medinter US LLC and Medinter Ltd.'s Interrogatory Nos. 1-6, and 8 -- filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Oct 16, 2020 | 170 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories to DermAvance Pharmaceuticals, Inc. and First Set of Requests for Production to DermAvance Pharmaceuticals, Inc. filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Oct 16, 2020 | 171 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Set of Requets for Admissions to Galderma Laboratories, L.P. and Galderma S.A., Third Set of Requests for Production Upon Galderma Laboratories, L.P. and Galderma S.A., and Third Set of Interrogatories to Galderma Laboratories, L.P. and Galderma S.A. filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Oct 16, 2020 | 172 | Notice (Other) (4) Docket Text: NOTICE of Service of Defendants' Sur-Reply Claim Construction Brief by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC (Liston, Ian) |
| Oct 15, 2020 | 169 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Michael Flynn regarding the Markman hearing scheduled for November 20, 2020. (Flynn, Michael) |
| Sep 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [168] STIPULATION TO EXTEND TIME (1) for Plaintiffs Galderma Laboratories L.P. and Galderma S.A. to serve their reply claim construction brief; and (2) for Defendants to serve their sur-reply claim construction brief to October 2, 2020 and October 15, 2020, filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Colm F. Connolly on 9/30/2020. (fms) |
| Sep 29, 2020 | 168 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (1) for Plaintiffs Galderma Laboratories L.P. and Galderma S.A. to serve their reply claim construction brief; and (2) for Defendants to serve their sur-reply claim construction brief to October 2, 2020 and October 15, 2020, respectively - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Sep 16, 2020 | 166 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Supplemental Response to Medinter US LLC and Medinter Ltd.'s Interrogatory No. 7 - filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Sep 16, 2020 | 167 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Dermavance Pharmaceuticals Second Amended Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories (Interrogatory No. 3) filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Sep 3, 2020 | 165 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC and Medinter Ltd.'s Second Set of Interrogatories and (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC and Medinter Ltd.'s Second Set of Requests for Production filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Aug 31, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [163] MOTION for Claim Construction re [160] Claim Construction Chart, , [161] MOTION for Claim Construction re [160] Claim Construction Chart, . The automatic referral generated by the system has been removed for these motions. (nmf) |
| Aug 31, 2020 | 163 | Motion for Miscellaneous Relief (3) Docket Text: MOTION for Claim Construction re [160] Claim Construction Chart, - filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) Modified on 9/2/2020 (nmf). |
| Aug 31, 2020 | 164 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Medinter US LLC and Medinter Ltd.'s Supplemental Response to Plaintiffs' Interrogatory No. 3 filed by Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Aug 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [162] MOTION for Pro Hac Vice Appearance of Attorney Erick J. Palmer filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 8/27/2020. (dlb) |
| Aug 26, 2020 | 161 | Motion for Miscellaneous Relief (4) Docket Text: MOTION for Claim Construction re [160] Claim Construction Chart, - filed by Galderma Laboratories, L.P., Galderma S.A.(Flynn, Michael) Modified on 9/2/2020 (nmf). |
| Aug 26, 2020 | 162 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Erick J. Palmer - filed by Galderma Laboratories, L.P., Galderma S.A.. Motions referred to Christopher J. Burke.(Flynn, Michael) |
| Aug 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [158] STIPULATION TO EXTEND TIME for the parties to file a joint claim construction chart to August 24, 2020 filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Colm F. Connolly on 8/24/2020. (fms) |
| Aug 24, 2020 | 159 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Mediation Conference is scheduled for October 1, 2020 at 10:00 AM Eastern Time by video conference before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 8/24/2020. (ceg) |
| Aug 24, 2020 | 160 | Claim Construction Chart (Main Document) (30) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 24, 2020 | 160 | Claim Construction Chart ('251 Patent) (6) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 24, 2020 | 160 | Claim Construction Chart ('758 Patent) (6) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 24, 2020 | 160 | Claim Construction Chart (Ex. 1 - Certified File History US6716251) (30) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 24, 2020 | 160 | Claim Construction Chart (Ex. 2 - Certified FIle History US6716251 Reexamination) (30) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 24, 2020 | 160 | Claim Construction Chart (Ex. 3 - Certified File History US7731758) (30) Docket Text: CLAIM Construction Chart by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) '251 Patent, # (2) '758 Patent, # (3) Ex. 1 - Certified File History US6716251, # (4) Ex. 2 - Certified FIle History US6716251 Reexamination, # (5) Ex. 3 - Certified File History US7731758)(Flynn, Michael) |
| Aug 21, 2020 | 158 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a joint claim construction chart to August 24, 2020 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Aug 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [156] STIPULATION TO EXTEND TIME for the parties to file a joint claim construction chart to August 21, 2020 filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Colm F. Connolly on 8/20/2020. (nmf) |
| Aug 20, 2020 | 157 | Redacted Document (30) Docket Text: REDACTED VERSION of [154] Answer to Amended Complaint by DermAvance Pharmaceuticals, Inc.. (Lee, Steven) |
| Aug 19, 2020 | 156 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a joint claim construction chart to August 21, 2020 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Aug 14, 2020 | 155 | Answer to Amended Complaint (7) Docket Text: ANSWER to Amended Complaint, re: [144] Amended Complaint, by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Aug 6, 2020 | 152 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Preliminary Identification of Initial Terms for Construction filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Aug 6, 2020 | 153 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of All Defendants' Preliminary Identification of Claim Terms for Construction and Preliminary Proposed Constructions filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Aug 5, 2020 | 150 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Defendants Medinter US LLC and Medinter Ltd.s Supplemental Responses to Plaintiffs First Set of Interrogatories, Nos. 2, 10, 11, & 13; (2) Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s Second Set of Requests for Production Upon Galderma Laboratories, L.P. and Galderma S.A.; and (3) Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s Second Set of Interrogatories to Galderma Laboratories, L.P. and Galderma S.A. filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Aug 5, 2020 | 151 | Redacted Document (30) Docket Text: REDACTED VERSION of [148] Answer to Amended Complaint by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Jul 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [149] STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to August 13, 2020 filed by Attwill Vascular Technologies LP, Attwill Medical Solutions, Inc., Anteco Pharma, LLC. Ordered by Judge Christopher J. Burke on 7/30/2020. (mlc) |
| Jul 30, 2020 | 149 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to August 13, 2020 - filed by Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP. (Brauerman, Stephen) |
| Jul 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [147] STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to August 13, 2020 filed by DermAvance Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 7/28/2020. (dlb) |
| Jul 28, 2020 | 147 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Second Amended Complaint to August 13, 2020 - filed by DermAvance Pharmaceuticals, Inc.. (Sharp, Melanie) |
| Jul 27, 2020 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER: A Status Telephone Conference is scheduled for August 24, 2020 at 11:45 AM Eastern Time before Judge Jennifer L. Hall. Plaintiffs' counsel shall initiate the call. The parties shall submit a confidential joint status letter to chambers on or before August 19, 2020. (*Any filings regarding mediation, including letters, are not to be efiled, but emailed to Cailah_Garfinkel@ded.uscourts.gov). ORDERED by Judge Jennifer L. Hall on 7/27/2020. (ceg) |
| Jul 16, 2020 | 145 | Redacted Document (29) Docket Text: REDACTED VERSION of [144] Amended Complaint, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [140] MOTION for Leave to File Second Amended Complaint filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 7/13/2020. (mlc) |
| Jul 8, 2020 | 143 | Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [140] MOTION for Leave to File Second Amended Complaint by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Second Amended Complaint, # (2) Exhibit B - Redline, # (3) [Proposed] Order)(Flynn, Michael) |
| Jul 8, 2020 | 143 | Redacted Document (Exhibit A - Second Amended Complaint) (29) Docket Text: REDACTED VERSION of [140] MOTION for Leave to File Second Amended Complaint by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Second Amended Complaint, # (2) Exhibit B - Redline, # (3) [Proposed] Order)(Flynn, Michael) |
| Jul 8, 2020 | 143 | Redacted Document (Exhibit B - Redline) (30) Docket Text: REDACTED VERSION of [140] MOTION for Leave to File Second Amended Complaint by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Second Amended Complaint, # (2) Exhibit B - Redline, # (3) [Proposed] Order)(Flynn, Michael) |
| Jul 8, 2020 | 143 | Redacted Document ([Proposed] Order) (1) Docket Text: REDACTED VERSION of [140] MOTION for Leave to File Second Amended Complaint by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibit A - Second Amended Complaint, # (2) Exhibit B - Redline, # (3) [Proposed] Order)(Flynn, Michael) |
| Jul 7, 2020 | 142 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn - re [140] MOTION for Leave to File Second Amended Complaint. (Flynn, Michael) |
| Jun 29, 2020 | 141 | Letter (4) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn - re [140] MOTION for Leave to File Second Amended Complaint. (Flynn, Michael) |
| May 21, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The letter filed at D.I. 140 has been removed as it was filed in error. (nms) |
| May 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I.[139] STIPULATION TO EXTEND TIME for the parties to move to join other parties, or to amend or supplement the pleadings (see D.I. 87 2) to June 29, 2020 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 5/14/2020. (dlb) |
| May 14, 2020 | N/A | Set Scheduling Order Deadlines (0) Docket Text: Per Stipulation Setting Scheduling Order Deadlines Amended Pleadings due by 6/29/2020. Joinder of Parties due by 6/29/2020. (dlb) |
| May 13, 2020 | 139 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to move to join other parties, or to amend or supplement the pleadings (see D.I. 87 2) to June 29, 2020 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 13, 2020 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER: A Status Telephone Conference is scheduled for July 27, 2020 at 11:30 AM Eastern Time before Judge Jennifer L. Hall to further discuss ADR. Plaintiffs' counsel shall initiate the call to chambers. ORDERED by Judge Jennifer L. Hall on 4/13/2020. (ceg) |
| Apr 1, 2020 | 137 | Redacted Document (30) Docket Text: REDACTED VERSION of [136] Answer to Amended Complaint by Defendants Medinter US LLC, Medinter LTD., and Medgraft Microtech, Inc. by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Mar 19, 2020 | N/A | Document Unsealed (0) Docket Text: Document Unsealed. [133] Memorandum Opinion unsealed. (dlb) |
| Mar 12, 2020 | 135 | Redacted Document (30) Docket Text: REDACTED VERSION of [130] Answer to Amended Complaint by DermAvance Pharmaceuticals, Inc.. (Higgins, James) |
| Mar 11, 2020 | 133 | Memorandum Opinion (13) Docket Text: MEMORANDUM OPINION. Signed by Judge Christopher J. Burke on 3/11/2020.This order has been emailed to local counsel. (mlc) Modified on 3/19/2020 Document unsealed(dlb). |
| Mar 11, 2020 | 134 | Order (1) Docket Text: ORDER regarding D.I. [133] Memorandum Opinion issued this date denying D.I. 47 motion to dismiss filed by Defendants Medinter US LLC, Medinter Ltd. and Medgraft Microtech, Inc.. Signed by Judge Christopher J. Burke on 3/11/2020. (mlc) |
| Mar 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed Defendants' Motion for Stay ("Motion"), (D.I. [118]), and the letter briefing related thereto, (D.I. 119-21), hereby DENIES the Motion. The Court expects to rule on the last pending motion to dismiss (filed by the Medinter Defendants and Defendant Medgraft) this week, and expects that it will deny that motion. In light of this, a stay would serve no purpose. Ordered by Judge Christopher J. Burke on 3/9/2020. (mlc) |
| Mar 6, 2020 | 131 | Order (2) Docket Text: ORDER: The referral to Magistrate Judge Christopher J. Burke under 28 U.S.C. § 636(b) is withdrawn as to claim construction only. The case remains referred to Magistrate Judge Burke for all other pretrial matters up to and including expert discovery matters (but not summary judgment motions, Daubert motions, or pre-trial motions in limine ). The parties shall comply with the claim construction procedures and briefing requirements set forth in Judge Connolly's patent form scheduling order on his website. ORDER, Setting Hearing: A Markman Hearing is set for 11/20/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/6/2020. (nmf) |
| Feb 24, 2020 | 128 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Feb 24, 2020 | 129 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals' First Amended Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories (Nos. 1 15) filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Feb 20, 2020 | 127 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Michael Flynn regarding no redactions to the Court's February 14, 2020 Memorandum Opinion - re [122] Memorandum Opinion. (Flynn, Michael) |
| Feb 19, 2020 | 126 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [121] Letter, by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Attachments: # (1) Ex. A (Redacted in its entirety))(Liston, Ian) |
| Feb 19, 2020 | 126 | Redacted Document (Ex. A (Redacted in its entirety)) (2) Docket Text: REDACTED VERSION of [121] Letter, by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Attachments: # (1) Ex. A (Redacted in its entirety))(Liston, Ian) |
| Feb 18, 2020 | 124 | Order (2) Docket Text: ERRATA ORDER replacing cover page of D.I. [98] Memorandum Opinion. Signed by Judge Christopher J. Burke on 2/18/2020. (dlb) |
| Feb 18, 2020 | 125 | Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [120] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-H)(Flynn, Michael) |
| Feb 18, 2020 | 125 | Redacted Document (Exhibits A-H) (30) Docket Text: REDACTED VERSION of [120] Letter by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-H)(Flynn, Michael) |
| Feb 14, 2020 | 122 | Memorandum Opinion (10) Docket Text: MEMORANDUM OPINION. Signed by Judge Christopher J. Burke on 2/14/2020.This order has been emailed to local counsel. (mlc) Modified on 2/20/2020 - Document unsealed(dlb). |
| Feb 14, 2020 | 123 | Order (1) Docket Text: ORDER regarding D.I. [122] Memorandum Opinion issued this date granting-in-part and denying-in-part D.I. 40 Motion to Dismiss For Lack of Subject Matter Jurisdiction and Failure to State a Claim filed by DermAvance Pharmaceuticals, Inc. Signed by Judge Christopher J. Burke on 2/14/2020. (mlc) |
| Feb 4, 2020 | 118 | Motion to Stay (Main Document) (2) Docket Text: MOTION to Stay re [87] Scheduling Order,, [117] Oral Order,,, on behalf of all Defendants - filed by Medgraft Microtech, Inc., Medinter Ltd.. (Attachments: # (1) Text of Proposed Order)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Feb 4, 2020 | 118 | Motion to Stay (Text of Proposed Order) (2) Docket Text: MOTION to Stay re [87] Scheduling Order,, [117] Oral Order,,, on behalf of all Defendants - filed by Medgraft Microtech, Inc., Medinter Ltd.. (Attachments: # (1) Text of Proposed Order)Motions referred to Christopher J. Burke.(Liston, Ian) |
| Feb 4, 2020 | 119 | Letter (5) Docket Text: Letter to The Honorable Christopher J. Burke from Defendants regarding Opening Letter in Support of Defendants' Motion to Stay - re [118] MOTION to Stay re [87] Scheduling Order,, [117] Oral Order,,, on behalf of all Defendants. (Liston, Ian) |
| Feb 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, understanding from communications from counsel that Defendants wish to move for a stay, and understanding that the parties have not met and conferred to agree on a truncated letter briefing process for such a motion (as the Court requested they do during the September 23, 2019 Case Management Conference), hereby ORDERS as follows: (1) By no later than February 11, 2020, Defendants shall file a one-page motion to stay and a letter brief in support thereof of no more than five (5) single-spaced pages; (2) By no later than February 18, 2020, Plaintiffs shall file an answering letter brief of no more than five (5) single-spaced pages; and (3) By no later than February 21, 2020, Defendants shall file a reply letter brief of no more than two (2) single-spaced pages. Ordered by Judge Christopher J. Burke on 2/3/2020. (mlc) |
| Jan 23, 2020 | 116 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Preliminary Infringement Contentions filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Jan 17, 2020 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Attwill Medical Solutions' and Attwill Vascular Technologies' Responses to Galderma Laboratories, LP and Galderma S.A.'s First Set of Requests for Production of Documents filed by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Jan 17, 2020 | 115 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Steven W. Lee on behalf of DermAvance Pharmaceuticals, Inc. (Lee, Steven) |
| Jan 6, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: A Status Telephone Conference is scheduled for Monday, April 13, 2020 at 11:00 AM Eastern Time before Judge Jennifer L. Hall to discuss ADR. Plaintiffs' counsel shall initiate the call. IT IS FURTHER ORDERED that if Plaintiff(s) and Defendant(s) jointly wish to schedule ADR with Judge Hall prior to the Status Teleconference, they should contact chambers by e-mail at Cailah_Garfinkel@ded.uscourts.gov or by phone. Additionally, if either party wishes to speak with Judge Hall regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. ORDERED by Judge Jennifer L. Hall on 1/6/2019. (ceg) |
| Dec 24, 2019 | 110 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants Medinter US LLC and Medinter Ltd.s Responses to Plaintiffs First Set of Requests for Production; (2) Defendants Medinter US LLC and Medinter Ltd.s Responses to Plaintiffs First Set of Interrogatories; (3) Defendant Medgraft Microtech, Inc.s Responses to Plaintiffs First Set of Requests for Production; and (4) Defendant Medgraft Microtech, Inc.s Responses to Plaintiffs First Set of Interrogatories filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Dec 24, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LP's Disclosure of Core Technical Documents and Sales Data filed by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Dec 24, 2019 | 112 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Core Technical Documents and Sales Data on December 23, 2019 filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Dec 23, 2019 | 108 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC and Medinter Ltd.'s First Set of Interrogatories and (2) Galderma Laboratories, L.P. and Galderma S.A.'s Objections and Responses to Medinter US LLC and Medinter Ltd.'s First Set of Requests for Production filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Dec 23, 2019 | 109 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals, Inc.'s Disclosures Concerning Core Technical Documents and Sales Date for the Accused Products filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Dec 16, 2019 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of DermAvance Pharmaceuticals' Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories; and DermAvance Pharmaceuticals' Responses to Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Nov 12, 2019 | 106 | Notice (Other) (30) Docket Text: NOTICE of Subpoena (Anteco Pharma LLC) by Galderma Laboratories, L.P., Galderma S.A. (Flynn, Michael) |
| Nov 8, 2019 | 105 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Defendants Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s First Set of Requests for Production upon Galderma Laboratories, L.P. and Galderma S.A.; and (2) Defendants Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s First Set of Interrogatories to Galderma Laboratories, L.P. and Galderma S.A. filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Nov 7, 2019 | 104 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Identification of Asserted Patents, Accused Products, and Damages Model filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Nov 6, 2019 | 100 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Disclosure Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Nov 6, 2019 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures of DermAvance Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery of Electronically Stored Information filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Nov 6, 2019 | 102 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Atwill Medical Solutions, Inc. and Attwill Vascular Technologies LP's Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Nov 6, 2019 | 103 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to paragraph 3 of the Default Standard for Discovery, including Discovery of Electronically Stored Information (ESI) filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Oct 25, 2019 | 98 | Memorandum Opinion (15) Docket Text: MEMORANDUM OPINION. Signed by Judge Christopher J. Burke on 10/25/2019. (dlb) |
| Oct 25, 2019 | 99 | Order (1) Docket Text: ORDER regarding Memorandum Opinion issued this date granting D.I. [36] MOTION to Dismiss for Improper Venue filed by Anteco Pharma, LLC. Signed by Judge Christopher J. Burke on 10/25/2019. (dlb) |
| Oct 24, 2019 | 97 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Anteco Pharma LLC, Attwill Medical Solutions, Inc. and Attwill Vascular Technologies LPs Initial Disclosures filed by Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Oct 23, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [96] STIPULATION TO EXTEND TIME for the parties to serve Initial Disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") to November 6, 2019 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 10/23/2019. (dlb) |
| Oct 23, 2019 | 96 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to serve Initial Disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") to November 6, 2019 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Oct 21, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [95] STIPULATION TO EXTEND TIME for Anteco Defendants to serve their Initial Disclosures to October 24, 2019 filed by Attwill Vascular Technologies LP, Attwill Medical Solutions, Inc., Anteco Pharma, LLC. Ordered by Judge Christopher J. Burke on 10/21/2019. (dlb) |
| Oct 21, 2019 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf (dlb) |
| Oct 18, 2019 | 95 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Anteco Defendants to serve their Initial Disclosures to October 24, 2019 - filed by Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP. (Brauerman, Stephen) |
| Oct 15, 2019 | 94 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things Propounded Upon Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc., (2) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories Propounded Upon Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc., (3) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things Propounded Upon DermAvance Pharmaceuticals, Inc., (4) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories Propounded Upon DermAvance Pharmaceuticals, Inc., (5) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Requests for Production of Documents and Things Propounded Upon Anteco Pharma LLC, Attwill Medical Solutions, Inc., and Attwill Vascular Technologies LP, and (6) Galderma Laboratories, L.P. and Galderma S.A.'s First Set of Interrogatories Propounded Upon Anteco Pharma LLC, Attwill Medical Solutions, Inc., and Attwill Vascular Technologies LP filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Oct 11, 2019 | 93 | Protective Order (12) Docket Text: Joint Stipulated PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 10/11/2019. (dlb) |
| Oct 10, 2019 | 89 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Galderma Laboratories, L.P. and Galderma S.A.'s Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories, L.P., Galderma S.A..(Flynn, Michael) |
| Oct 10, 2019 | 90 | Proposed Order (12) Docket Text: Joint PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Oct 10, 2019 | 91 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc.s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1); and the Scheduling Order re [87] Scheduling Order,, filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC.(Liston, Ian) |
| Oct 10, 2019 | 92 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Disclosure of DermAvance Pharmaceuticals Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by DermAvance Pharmaceuticals, Inc..(Higgins, James) |
| Oct 8, 2019 | 88 | Order Setting Teleconference (3) Docket Text: ORDER Setting Teleconference: A Telephone Conference is scheduled for 1/6/2020 at 10:00 a.m. Eastern Time before Judge Jennifer L. Hall to discuss ADR. Plaintiffs' counsel shall initiate the call. Signed by Judge Jennifer L. Hall on 10/8/2019. (ceg) |
| Sep 30, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Sep 30, 2019 | 87 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/15/2020. Amended Pleadings due by 5/15/2020. Discovery due by 2/2/2021. Status Report due by 10/22/2020. Dispositive Motions due by 4/30/2021. A Markman Hearing is set for 11/4/2020 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. A Pretrial Conference is set for 10/6/2021 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 10/18/2021 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Please see Order for further details and deadlines. Signed by Judge Christopher J. Burke on 9/30/20119. (dlb) Modified on 9/30/2019 (dlb). |
| Sep 27, 2019 | 86 | Proposed Order (18) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Sep 23, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Case Management/Scheduling Conference held on 9/23/2019. The Court resolved the parties' disputes and provided key dates. Plaintiffs' counsel shall submit a revised proposed scheduling order by the close of business on 9/27/19. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: M. Flynn, J. Mahoney, C. McCraw, E. Choi for Plaintiffs; I. Liston, J. Peuscher-Funk for Defendants Medinter US LLC and Medinter Ltd., S. Brauerman for Defendants Anteco Pharma, LLC, Attwill Vascular Techs. LP and Attwill Medical Solutions, Inc.; J. Higgins, D. McCallum for Defendant DermAdvance Pharms., Inc. (mlc) |
| Sep 13, 2019 | 85 | Consent to Magistrate Judge Disposition on Motion (1) Docket Text: CONSENT to Magistrate Judge Disposition on Motion by Anteco Pharma, LLC, DermAvance Pharmaceuticals, Inc., Galderma Laboratories, L.P., Galderma S.A., Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC re [40] MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter , [36] MOTION to Dismiss for Improper Venue , [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6) Motion referred to Christopher J. Burke. (nmf) |
| Sep 9, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order requiring case management submissions was entered on this docket in error and has been removed. (dlb) |
| Sep 9, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The entry for the Case Management/Scheduling Conference set for 9/23/19 has been corrected to reflect that it will be an in-person conference and not a teleconference. (dlb) |
| Sep 9, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' September 5, 2019 letter, (D.I. 82), hereby ORDERS that by no later than September 16, 2019, the parties shall submit a jointly signed "Notice, Consent and Reference of a Dispositive Motion to a Magistrate Judge" form (available on Judge Burke's portion of the District Court's website) in light of their consent to the Court's jurisdiction for the purpose of resolving the pending motions to dismiss, (D.I. 36; D.I. 40; D.I. 47).. Signed by Judge Christopher J. Burke on 9/9/2019. (dlb) |
| Sep 9, 2019 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting Case Management/Scheduling Conference: A Case Management/Scheduling Conference is set for 9/23/2019 at 03:00 PM in Courtroom 2A before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 9/9/2019. (dlb) |
| Sep 5, 2019 | 82 | Letter (Main Document) (3) Docket Text: Letter to The Honorable Christopher J. Burke from Michael J. Flynn regarding a description of the case, the Parties' positions regarding certain disputes in the proposed Scheduling Order, and a list of the three most significant topics discussed during the Parties' review of the Checklist items. (Attachments: # (1) Proposed Scheduling Order, # (2) Case Management Checklist)(Flynn, Michael) |
| Sep 5, 2019 | 82 | Letter (Proposed Scheduling Order) (24) Docket Text: Letter to The Honorable Christopher J. Burke from Michael J. Flynn regarding a description of the case, the Parties' positions regarding certain disputes in the proposed Scheduling Order, and a list of the three most significant topics discussed during the Parties' review of the Checklist items. (Attachments: # (1) Proposed Scheduling Order, # (2) Case Management Checklist)(Flynn, Michael) |
| Sep 5, 2019 | 82 | Letter (Case Management Checklist) (4) Docket Text: Letter to The Honorable Christopher J. Burke from Michael J. Flynn regarding a description of the case, the Parties' positions regarding certain disputes in the proposed Scheduling Order, and a list of the three most significant topics discussed during the Parties' review of the Checklist items. (Attachments: # (1) Proposed Scheduling Order, # (2) Case Management Checklist)(Flynn, Michael) |
| Sep 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [81] STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order, Joint Letter, and Checklist Pursuant to D.I. 79 to September 5, 2019 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 9/4/2019. (dlb) |
| Sep 3, 2019 | 81 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order, Joint Letter, and Checklist Pursuant to D.I. 79 to September 5, 2019 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Aug 30, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [80] STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order, Joint Letter, and Checklist pursuant to D.I. 79 to September 3, 2019 filed by Galderma S.A., Galderma Laboratories, L.P. Ordered by Judge Christopher J. Burke on 8/30/2019. (mlc) |
| Aug 30, 2019 | 80 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order, Joint Letter, and Checklist pursuant to D.I. 79 to September 3, 2019 - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jul 31, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist ("Checklist"). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 16 (i.e., regarding the portions of the case schedule leading up to but not including the case dispositive motion stage of the case) and that is consistent with paragraphs 19-25 of Judge Connolly's "Patent Case Form Scheduling Order for Cases Where Infringement is Alleged" (i.e., regarding the portions of the case schedule from the case dispositive motion stage through trial); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties' review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and both Scheduling Orders can be found on Judge Burke's/Judge Connolly's portions of the District Court's website. Ordered by Judge Christopher J. Burke on 7/31/2019. (dlb) |
| Jul 30, 2019 | 78 | Order Referring Case to Magistrate Judge (1) Docket Text: ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke to hear and resolve all pretrial matters up to and including expert discovery matters (but not summary judgment motions, Daubert motions, or pre-trial motions in limine). Signed by Judge Colm F. Connolly on 7/30/2019. Motions referred to Magistrate Judge Christopher J. Burke.(nmf) |
| Jul 1, 2019 | 77 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel, Michelle M. Ovanesian by DermAvance Pharmaceuticals, Inc. (Higgins, James) |
| May 24, 2019 | 76 | Reply Brief (Main Document) (13) Docket Text: REPLY BRIEF re [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6) filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Attachments: # (1) Certificate of Service)(Liston, Ian) |
| May 24, 2019 | 76 | Reply Brief (Certificate of Service) (1) Docket Text: REPLY BRIEF re [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6) filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Attachments: # (1) Certificate of Service)(Liston, Ian) |
| May 8, 2019 | 75 | Redacted Document (26) Docket Text: REDACTED VERSION of [65] Answering Brief in Opposition, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| May 7, 2019 | 73 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from James L. Higgins, Esq. regarding Oral Argument on DermAvance's Motion to Dismiss - re [40] MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter . (Higgins, James) |
| May 7, 2019 | 74 | Redacted Document (16) Docket Text: REDACTED VERSION of [68] Reply Brief in Support of Motion to Dismiss by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| May 3, 2019 | 69 | Reply Brief (10) Docket Text: REPLY BRIEF re [36] MOTION to Dismiss for Improper Venue filed by Anteco Pharma, LLC. (Brauerman, Stephen) |
| May 3, 2019 | 72 | Declaration (19) Docket Text: DECLARATION re [71] Answering Brief in Opposition, -- Declaration of B. Clayton McCraw -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| May 1, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [67] MOTION to Extend Deadline for Defendant to File Reply Brief in Support of Motion to Dismiss and for Plaintiffs' Response to Motion to Dismiss by Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. to May 3, 2019 filed by Anteco Pharma, LLC. Signed by Judge Colm F. Connolly on 5/1/2019. (fms) |
| May 1, 2019 | N/A | Set Briefing Schedule (0) Docket Text: Set Briefing Schedule: re [36] MOTION to Dismiss for Improper Venue . Reply Brief due 5/3/2019. (fms) |
| May 1, 2019 | N/A | Set Briefing Schedule (0) Docket Text: Set Briefing Schedule: re [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6). Answering Brief due 5/3/2019. (fms) |
| May 1, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Richard L. Bolton for Anteco Pharma, LLC, Attwill Medical Solutions, Inc., and Attwill Vascular Technologies LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
| Apr 30, 2019 | 67 | Motion for Miscellaneous Relief (2) Docket Text: MOTION to Extend Deadline for Defendant to File Reply Brief in Support of Motion to Dismiss and for Plaintiffs' Response to Motion to Dismiss by Medinter US LLC, Medinter Ltd., and Medgraft Microtech, Inc. to May 3, 2019 - filed by Anteco Pharma, LLC. (Brauerman, Stephen) |
| Apr 23, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [66] MOTION for Pro Hac Vice Appearance of Attorney Richard L. Bolton filed by Attwill Vascular Technologies LP, Attwill Medical Solutions, Inc., Anteco Pharma, LLC. Signed by Judge Colm F. Connolly on 4/23/2019. (fms) |
| Apr 18, 2019 | 66 | Motion for Leave to Appear Pro Hac Vice (Main Document) (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard L. Bolton - filed by Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP. (Attachments: # (1) Certification of Richard L. Bolton)(Brauerman, Stephen) |
| Apr 18, 2019 | 66 | Motion for Leave to Appear Pro Hac Vice (Certification of Richard L. Bolton) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard L. Bolton - filed by Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP. (Attachments: # (1) Certification of Richard L. Bolton)(Brauerman, Stephen) |
| Apr 16, 2019 | 63 | Answering Brief in Opposition (18) Docket Text: ANSWERING BRIEF in Opposition re [36] MOTION to Dismiss for Improper Venue (Anteco Pharma LLC) -- filed by Galderma Laboratories, L.P., Galderma S.A..Reply Brief due date per Local Rules is 4/23/2019. (Flynn, Michael) |
| Apr 16, 2019 | 64 | Declaration (19) Docket Text: DECLARATION re [63] Answering Brief in Opposition -- Declaration of Ying-Zi Yang -- by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Diyang Liu,Matt Blair,Aden M. Allen for Medgraft Microtech, Inc., for Medinter Ltd.,for Medinter US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Apr 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [55] MOTION for Pro Hac Vice Appearance of Attorney Diyang Liu, Aden M. Allen and Matt Blair filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. Signed by Judge Colm F. Connolly on 4/9/2019. (fms) |
| Apr 9, 2019 | 56 | Redacted Document (4) Docket Text: REDACTED VERSION of [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6) by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Apr 9, 2019 | 57 | Redacted Document (25) Docket Text: REDACTED VERSION of [48] Opening Brief in Support, by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Apr 9, 2019 | 58 | Redacted Document (30) Docket Text: REDACTED VERSION of [49] Declaration, by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Apr 9, 2019 | 59 | Redacted Document (20) Docket Text: REDACTED VERSION of [50] Compendium of Unreported Decisions, by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Apr 9, 2019 | 60 | Redacted Document (1) Docket Text: REDACTED VERSION of [51] Disclosure Statement by Medinter US LLC. (Liston, Ian) |
| Apr 9, 2019 | 61 | Redacted Document (1) Docket Text: REDACTED VERSION of [52] Disclosure Statement by Medinter Ltd.. (Liston, Ian) |
| Apr 9, 2019 | 62 | Redacted Document (1) Docket Text: REDACTED VERSION of [53] Disclosure Statement by Medgraft Microtech, Inc.. (Liston, Ian) |
| Apr 8, 2019 | 55 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Diyang Liu, Aden M. Allen and Matt Blair - filed by Medgraft Microtech, Inc., Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Apr 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [54] STIPULATION TO EXTEND TIME for (1) Plaintiffs Galderma Laboratories LLP and Galderma S.A. to file their opposition to Defendants Medinter US LLC, Medinter Ltd. and Medgraft Microtech Inc.'s Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(1) a filed by Galderma S.A., Galderma Laboratories, L.P. Set Briefing Schedule: re [47] MOTION to Dismiss Based upon Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6). (Answering Brief due 4/30/2019., Reply Brief due 5/21/2019.). Signed by Judge Colm F. Connolly on 4/4/2019. (fms) |
| Apr 4, 2019 | 54 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for (1) Plaintiffs Galderma Laboratories LLP and Galderma S.A. to file their opposition to Defendants Medinter US LLC, Medinter Ltd. and Medgraft Microtech Inc.'s Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(1) and 12(b)(6) (D.I. 47); and (2) Defendants Medinter US LLC, Medinter Ltd. and Medgraft Microtech Inc. to file a reply in support of their Motion to April 30, 2019 and May 21, 2019, respectively - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Apr 3, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the Sealed Declaration at D.I. [49] has been removed and replaced. (fms) |
| Mar 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [46] Joint STIPULATION TO EXTEND TIME for Plaintiffs to file Opposition and Defendants to file Reply to Motions to April 16, 2019 and April 30, 2019 Respectively filed by Galderma S.A., Galderma Laboratories, L.P. Set Briefing Schedule: re [40] MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter , [36] MOTION to Dismiss for Improper Venue . (Answering Brief due 4/16/2019., Reply Brief due 4/30/2019.). Signed by Judge Colm F. Connolly on 3/28/2019. (fms) |
| Mar 27, 2019 | 46 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for Plaintiffs to file Opposition and Defendants to file Reply to Motions to April 16, 2019 and April 30, 2019 Respectively - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Mar 26, 2019 | 43 | Redacted Document (4) Docket Text: REDACTED VERSION of [40] MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Mar 26, 2019 | 44 | Redacted Document (23) Docket Text: REDACTED VERSION of [41] Opening Brief in Support, of Motion to Dismiss by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Mar 26, 2019 | 45 | Redacted Document (30) Docket Text: REDACTED VERSION of [42] Declaration, of Nicole M. DeAbrantes by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Mar 19, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The correct document has been attached at D.I. [35]. (fms) |
| Mar 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicole W. Stafford for Medinter Ltd. and Medinter US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Mar 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [39] SEALED STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to April 2, 2019 filed by Medgraft Microtech, Inc. Signed by Judge Colm F. Connolly on 3/19/2019. (fms) |
| Mar 18, 2019 | 35 | Answer to Amended Complaint (7) Docket Text: ANSWER to Amended Complaint, re: [33] Amended Complaint, / Answer and Affirmative Defenses to First Amended Complaint by Defendants Attwill Medical Solutions, Inc., and Attwill Vascular Technologies LP by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) (Main Document 35 replaced on 3/19/2019) (fms). |
| Mar 18, 2019 | 36 | Motion to Dismiss/Improper Venue (Main Document) (1) Docket Text: MOTION to Dismiss for Improper Venue - filed by Anteco Pharma, LLC. (Attachments: # (1) [Proposed] Order Granting Anteco Pharma LLC's Renewed Motion to Dismiss for Improper Venue)(Brauerman, Stephen) |
| Mar 18, 2019 | 36 | Motion to Dismiss/Improper Venue ([Proposed] Order Granting Anteco Pharma LLC's Renewed Motion to Dismiss fo) (1) Docket Text: MOTION to Dismiss for Improper Venue - filed by Anteco Pharma, LLC. (Attachments: # (1) [Proposed] Order Granting Anteco Pharma LLC's Renewed Motion to Dismiss for Improper Venue)(Brauerman, Stephen) |
| Mar 18, 2019 | 37 | Opening Brief in Support (9) Docket Text: OPENING BRIEF in Support re [36] MOTION to Dismiss for Improper Venue filed by Anteco Pharma, LLC.Answering Brief/Response due date per Local Rules is 4/1/2019. (Brauerman, Stephen) |
| Mar 18, 2019 | 38 | Declaration (3) Docket Text: DECLARATION re [36] MOTION to Dismiss for Improper Venue / Declaration of Howard Teeter by Anteco Pharma, LLC. (Brauerman, Stephen) |
| Mar 12, 2019 | 34 | Redacted Document (Main Document) (28) Docket Text: REDACTED VERSION of [33] Amended Complaint, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-N)(Flynn, Michael) |
| Mar 12, 2019 | 34 | Redacted Document (Exhibits A-N) (30) Docket Text: REDACTED VERSION of [33] Amended Complaint, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # (1) Exhibits A-N)(Flynn, Michael) |
| Feb 25, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [30] MOTION for Pro Hac Vice Appearance of Attorney Nicole W. Stafford filed by Medinter Ltd., Medinter US LLC. Signed by Judge Colm F. Connolly on 2/25/2019. (fms) |
| Feb 25, 2019 | 30 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicole W. Stafford - filed by Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Feb 25, 2019 | 31 | Redacted Document (21) Docket Text: REDACTED VERSION of [21] Opening Brief in Support of Motion to Dismiss Based upon Rules 12(b)(1) and 12(b)(6) by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Feb 25, 2019 | 32 | Redacted Document (30) Docket Text: REDACTED VERSION of [22] Declaration, [Declaration of Nicole M. DeAbrantes in Support of DermAdvance Pharms., Inc.'s Opening Brief in Support of its Motion to Dismiss] by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Feb 22, 2019 | 26 | Motion to Dismiss/Improper Venue (Main Document) (1) Docket Text: MOTION to Dismiss for Improper Venue - filed by Anteco Pharma, LLC. (Attachments: # (1) [Proposed] Order Granting Anteco Pharma LLC's Motion to Dismiss for Improper Venue)(Brauerman, Stephen) |
| Feb 22, 2019 | 26 | Motion to Dismiss/Improper Venue ([Proposed] Order Granting Anteco Pharma LLC's Motion to Dismiss for Improp) (1) Docket Text: MOTION to Dismiss for Improper Venue - filed by Anteco Pharma, LLC. (Attachments: # (1) [Proposed] Order Granting Anteco Pharma LLC's Motion to Dismiss for Improper Venue)(Brauerman, Stephen) |
| Feb 22, 2019 | 27 | Declaration (3) Docket Text: DECLARATION re [26] MOTION to Dismiss for Improper Venue / Declaration of Howard Teeter by Anteco Pharma, LLC. (Brauerman, Stephen) |
| Feb 22, 2019 | 28 | Opening Brief in Support (9) Docket Text: OPENING BRIEF in Support re [26] MOTION to Dismiss for Improper Venue filed by Anteco Pharma, LLC.Answering Brief/Response due date per Local Rules is 3/8/2019. (Brauerman, Stephen) |
| Feb 22, 2019 | 29 | Answer to Complaint (6) Docket Text: ANSWER to [1] Complaint, / Answer and Affirmative Defenses by Defendants Attwill Medical Solutions, Inc., and Attwill Vascular Technologies LP by Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP.(Brauerman, Stephen) |
| Feb 21, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] MOTION for Extension of Time to File Answer re [1] Complaint, (as to Defendants Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, and Anteco Pharma, LLC) -- Unopposed -- filed by Galderma S.A., Galderma Laboratories, L.P. Set/Reset Answer Deadlines: Anteco Pharma, LLC answer due 2/22/2019; Attwill Medical Solutions, Inc. answer due 2/22/2019; Attwill Vascular Technologies LP answer due 2/22/2019. Signed by Judge Colm F. Connolly on 2/21/2019. (fms) |
| Feb 20, 2019 | 25 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE of DermAvance Pharms., Inc.'s Opening Brief in Support of DermAvance Pharms., Inc.'s Motion to Dismiss Complaint and the Declaration of Nicole M. DeAbrantes in Support of DermAvance Pharms., Inc.s Motion to Dismiss Complaint by DermAvance Pharmaceuticals, Inc. re [22] Declaration, [21] Opening Brief in Support (Ovanesian, Michelle) |
| Feb 19, 2019 | 20 | Motion to Dismiss (Main Document) (2) Docket Text: MOTION to Dismiss Based upon Rules 12(b)(1) and 12(b)(6) - filed by DermAvance Pharmaceuticals, Inc.. (Attachments: # (1) Text of Proposed Order)(Ovanesian, Michelle) |
| Feb 19, 2019 | 20 | Motion to Dismiss (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss Based upon Rules 12(b)(1) and 12(b)(6) - filed by DermAvance Pharmaceuticals, Inc.. (Attachments: # (1) Text of Proposed Order)(Ovanesian, Michelle) |
| Feb 19, 2019 | 23 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by DermAvance Pharmaceuticals, Inc.. (Ovanesian, Michelle) |
| Feb 19, 2019 | 24 | Motion for Extension of Time to File Answer (2) Docket Text: MOTION for Extension of Time to File Answer re [1] Complaint, (as to Defendants Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, and Anteco Pharma, LLC) -- Unopposed -- - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jan 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Barry Clayton McCraw,Joseph A. Mahoney,Ying-Zi Yang for Galderma Laboratories, L.P., Galderma S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Extension of Time to File Answer re [1] Complaint, (as to Defendants Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, and Anteco Pharma, LLC) -- Unopposed -- filed by Galderma S.A., Galderma Laboratories, L.P., Set/Reset Answer Deadlines: Anteco Pharma, LLC answer due 2/19/2019; Attwill Medical Solutions, Inc. answer due 2/19/2019; Attwill Vascular Technologies LP answer due 2/19/2019. Signed by Judge Colm F. Connolly on 1/18/2019. (nmf) |
| Jan 18, 2019 | 19 | Motion for Extension of Time to File Answer (2) Docket Text: MOTION for Extension of Time to File Answer re [1] Complaint, (as to Defendants Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, and Anteco Pharma, LLC) -- Unopposed -- - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Jan 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Daniel R. McCallum, Steven Lieberman, Nicole M DeAbrantes, and Rachel Echols for DermAvance Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 15, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] MOTION for Pro Hac Vice Appearance of Attorney Steven Lieberman, Rachel M. Echols, Daniel R. McCallum and Nicole M. DeAbrantes filed by DermAvance Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 1/15/2019. (fms) |
| Jan 14, 2019 | 18 | Motion for Leave to Appear Pro Hac Vice (Main Document) (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven Lieberman, Rachel M. Echols, Daniel R. McCallum and Nicole M. DeAbrantes - filed by DermAvance Pharmaceuticals, Inc.. (Attachments: # (1) Certification by Counsel)(Ovanesian, Michelle) |
| Jan 14, 2019 | 18 | Motion for Leave to Appear Pro Hac Vice (Certification by Counsel) (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven Lieberman, Rachel M. Echols, Daniel R. McCallum and Nicole M. DeAbrantes - filed by DermAvance Pharmaceuticals, Inc.. (Attachments: # (1) Certification by Counsel)(Ovanesian, Michelle) |
| Jan 10, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] STIPULATION TO EXTEND TIME to move, plead, answer or otherwise respond to the Complaint to February 19, 2019 filed by DermAvance Pharmaceuticals, Inc. Set/Reset Answer Deadlines: DermAvance Pharmaceuticals, Inc. answer due 2/19/2019. Signed by Judge Colm F. Connolly on 1/10/2019. (fms) |
| Jan 10, 2019 | 17 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, plead, answer or otherwise respond to the Complaint to February 19, 2019 - filed by DermAvance Pharmaceuticals, Inc.. (Sharp, Melanie) |
| Dec 20, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION Unopposed Motion to Extend Time filed by Galderma S.A., Galderma Laboratories, L.P. Set/Reset Answer Deadlines: Attwill Medical Solutions, Inc. answer due 1/21/2019; Attwill Vascular Technologies LP answer due 1/21/2019. Signed by Judge Colm F. Connolly on 12/20/2018. (fms) |
| Dec 20, 2018 | 16 | Motion for Miscellaneous Relief (2) Docket Text: MOTION Unopposed Motion to Extend Time - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 19, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] Stipulation filed by Medinter Ltd., Medinter US LLC, Set/Reset Answer Deadlines: Medinter Ltd. answer due 3/6/2019; Medinter US LLC answer due 3/6/2019. Signed by Judge Colm F. Connolly on 12/19/2018. (fms) |
| Dec 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Extension of Time to File Answer re [1] Complaint, as to Defendant DermaVance Pharmaceuticals, Inc. (Unopposed) filed by Galderma S.A., Galderma Laboratories, L.P. Set/Reset Answer Deadlines: DermAvance Pharmaceuticals, Inc. answer due 1/21/2019. Signed by Judge Colm F. Connolly on 12/18/2018. (fms) |
| Dec 18, 2018 | 13 | Motion for Extension of Time to File Answer (2) Docket Text: MOTION for Extension of Time to File Answer re [1] Complaint, as to Defendant DermaVance Pharmaceuticals, Inc. (Unopposed) - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 18, 2018 | 14 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Ian Robert Liston on behalf of Medinter Ltd., Medinter US LLC (Liston, Ian) |
| Dec 18, 2018 | 15 | Stipulation (2) Docket Text: STIPULATION Concerning Service and Extension of Time to Move, Answer, or Otherwise Respond to the Complaint re [1] Complaint, by Medinter Ltd., Medinter US LLC. (Liston, Ian) |
| Dec 11, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Summons Returned Executed for Defendant Attwill Vascular Technologies LP (D.I. 6) removed from docket per filing party's request. (ceg) |
| Dec 11, 2018 | 12 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P.. Attwill Vascular Technologies LP served on 12/11/2018, answer due 1/2/2019. (Blumenfeld, Jack) |
| Dec 7, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Joseph A. Mahoney, B. Clayton McCraw and Ying-Zi Yang filed by Galderma S.A., Galderma Laboratories, L.P. Signed by Judge Colm F. Connolly on 12/7/2018. (fms) |
| Dec 7, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph A. Mahoney, B. Clayton McCraw and Ying-Zi Yang - filed by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 6, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Dec 3, 2018 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P.. Attwill Medical Solutions, Inc. served on 11/30/2018, answer due 12/21/2018. (Flynn, Michael) |
| Dec 3, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P.. DermAvance Pharmaceuticals, Inc. served on 11/30/2018, answer due 12/21/2018. (Flynn, Michael) |
| Dec 3, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P.. Medinter US LLC served on 11/30/2018, answer due 12/21/2018. (Flynn, Michael) |
| Dec 3, 2018 | 9 | Declaration (9) Docket Text: DECLARATION of Mailing (as to service on Anteco Pharma, LLC) by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Dec 3, 2018 | 10 | Declaration (9) Docket Text: DECLARATION of Mailing (as to service on Medinter Ltd.) by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) |
| Nov 30, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Anteco Pharma, LLC on 11/30/2018; Attwill Medical Solutions, Inc. on 11/30/2018; Attwill Vascular Technologies LP on 11/30/2018; DermAvance Pharmaceuticals, Inc. on 11/30/2018; Medinter Ltd. on 11/30/2018; Medinter US LLC on 11/30/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Nov 29, 2018 | 1 | Complaint* (1) |
| Nov 29, 2018 | 1 | Complaint (Main Document) (17) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, DermAvance Pharmaceuticals, Inc., Medinter Ltd., Medinter US LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2514215.) - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Exhibit A-J, # (2) Civil Cover Sheet)(nmg) |
| Nov 29, 2018 | 1 | Complaint (Exhibit A-J) (30) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, DermAvance Pharmaceuticals, Inc., Medinter Ltd., Medinter US LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2514215.) - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Exhibit A-J, # (2) Civil Cover Sheet)(nmg) |
| Nov 29, 2018 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Anteco Pharma, LLC, Attwill Medical Solutions, Inc., Attwill Vascular Technologies LP, DermAvance Pharmaceuticals, Inc., Medinter Ltd., Medinter US LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2514215.) - filed by Galderma S.A., Galderma Laboratories, L.P.. (Attachments: # (1) Exhibit A-J, # (2) Civil Cover Sheet)(nmg) |
| Nov 29, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Nov 29, 2018 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,716,251 B1; 7,731,758 B2. (nmg) |
| Nov 29, 2018 | 4 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Galderma Pharma S.A. for Galderma S.A.; Other Affiliate Galderma General, L.L.C., Other Affiliate Galderma Limited, L.L.C., Other Affiliate Nestle Skin Health U.S., Inc. for Galderma Laboratories, L.P. filed by Galderma Laboratories, L.P., Galderma S.A.. (nmg) |
